syndrome	score	normalized_score
DRAVET SYNDROME	2.9178999999999995	100.0
CHILDHOOD ABSENCE EPILEPSY	2.52074085	86.38887042050793
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	2.333333	79.96617430343743
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	1.6684777040000003	57.18077055416568
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	1.50235294	51.48747181191954
MYOCLONIC-ASTASTIC EPILEPSY	1.344235154	46.06858199389973
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	1.31295385	44.99653346584873
LENNOX-GASTAUT SYNDROME	1.23257131	42.24172555605059
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	40.90935261660783
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	1.164156114	39.89705315466603
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	39.48443263991228
MYOPATHIC EHLERS-DANLOS SYNDROME	1.1036118	37.82212550121663
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.09399367	37.49250042839029
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	1.074447264	36.82262120017822
HYPEREKPLEXIA-EPILEPSY SYNDROME	1.0686936999999999	36.62543952842798
SLC35A2-CDG	1.045923054	35.8450616539292
BENIGN OCCIPITAL EPILEPSY	1.027027	35.19747078378286
ROLANDIC EPILEPSY	1.021574	35.01058980773845
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0010869729999998	34.30847434798999
JOUBERT SYNDROME 1	1.000545554	34.2899192569999
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	34.27122245450496
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	1.0	34.27122245450496
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	34.27122245450496
HEREDITARY ANGIOEDEMA TYPE 1	1.0	34.27122245450496
MYOCLONIC EPILEPSY OF LAFORA	0.9378890400000001	32.1426039274821
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.92074085	31.554914493299986
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.8807085139999999	30.182957400870492
LAFORA DISEASE	0.7819456600000001	26.798233661194704
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	26.409990061345496
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.75940841	26.02585455293191
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.750931904	25.735354330168963
EARLY MYOCLONIC ENCEPHALOPATHY	0.719145614	24.645999314575555
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.673464634	23.080456287055764
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.6467644	22.165406628054427
CENTRALOPATHIC EPILEPSY	0.6047009	20.72383906233936
SPINOCEREBELLAR ATAXIA TYPE 10	0.58389163	20.0106799410535
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5698413	19.529157956064296
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.277973885328493
PERIORAL MYOCLONIA WITH ABSENCES	0.53122691	18.205795606429284
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	18.061859556530386
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	17.87312670070942
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5116122	17.53357551663868
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.508878884	17.439901435964224
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.376957743582718
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.500541419	17.154166318242574
PAROXYSMAL HEMICRANIA	0.5	17.13561122725248
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	17.13561122725248
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	17.13561122725248
PYKNOACHONDROGENESIS	0.5	17.13561122725248
INHALATIONAL ANTHRAX	0.5	17.13561122725248
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.5	17.13561122725248
CREST SYNDROME	0.5	17.13561122725248
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.4956707	16.987240823880192
EPILEPSY, JUVENILE ABSENCE	0.48251765999999996	16.53647006408719
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.47200919	16.1763319510607
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.438861914	15.040334281503826
MYOCLONIC EPILEPSY OF INFANCY	0.438861914	15.040334281503826
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.40080681999999995	13.736139689502725
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39264330999999997	13.456366222283151
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.252567257274068
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.34826975000000004	11.93563007642483
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	11.836349909181262
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	11.817653106686318
SPINOCEREBELLAR ATAXIA TYPE 42	0.34166633	11.709322800644301
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	11.66507591075774
COG4-CDG	0.333878554	11.442426196922446
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.333874419	11.442284485417597
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.333874419	11.442284485417597
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	11.4237293944275
PLACENTAL INSUFFICIENCY	0.333333	11.4237293944275
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.4237293944275
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	11.4237293944275
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.32705855400000006	11.208696459782724
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.3269231	11.20405428561637
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.32566591	11.160968847458792
JUVENILE MYOCLONIC EPILEPSY	0.31234589999999995	10.70447582165256
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.31148864	10.67509647349121
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.325282360601804
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.29551881399999996	10.127791014085473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.29416480999999994	10.081387641797182
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.272710404	9.346118921141919
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.26704225	9.151864354501527
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.26636899999999997	9.12879125398403
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.264957434	9.080415161588814
LANDAU-KLEFFNER SYNDROME	0.25985890300000003	8.905682271496627
PALLISTER-HALL SYNDROME	0.25867328399999995	8.865049659001336
HYPEREKPLEXIA 1; HKPX1	0.2542735	8.714263682785566
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25235294	8.648443743788343
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	8.635136228109259
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.25157535	8.621794783919944
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.25157535	8.621794783919944
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.251086973	8.60505750711128
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.250541419	8.586360704616334
DYSTONIA 6, TORSION	0.25	8.56780561362624
HYPERPARATHYROIDISM 2	0.25	8.56780561362624
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.24566625000000003	8.41928270331403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	8.329454539223416
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.23864513	8.178660337914256
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.04053613900408
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	7.742868158607219
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.225180394	7.717207375167074
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.22098719400000003	7.5735012851708445
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2098612	7.192199869769356
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.2088473	7.157452277322735
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20344828	6.972421261866413
KAGAMI-OGATA SYNDROME	0.201086973	6.891496384386032
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	6.854244490900991
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.19816368000000004	6.7913115596833356
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.18796611400000002	6.44182850680284
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.1853263	6.351358853970322
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.18296851	6.270554508379315
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.242090338942392
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.179201484	6.141453922341411
PFAPA SYNDROME	0.17543893000000002	6.012506597210324
DISTAL 17P13.1 MICRODELETION SYNDROME	0.17422827000000002	5.971015799033553
UNILATERAL POLYMICROGYRIA	0.17035464	5.838261763597108
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	5.730436923815073
PEMPHIGUS VULGARIS	0.166667	5.711881832824979
PITYRIASIS RUBRA PILARIS	0.166667	5.711881832824979
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	5.711881832824979
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	5.711881832824979
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.166616824	5.7101622399671
JUVENILE ABSENCE EPILEPSY	0.16503685	5.656014599540767
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.163230184	5.594097947153776
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.4664553274615315
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.4664553274615315
EPILEPSY, IDIOPATHIC GENERALIZED	0.15622691	5.3540871859899255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.308504540936975
FEBRILE CONVULSIONS, FAMILIAL, 9	0.15362399999999998	5.2648822783508695
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.231906987902259
GLYCINE ENCEPHALOPATHY	0.15211625999999998	5.213210185407314
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.149118154	5.1104614277391285
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.0876760684053615
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.147513204	5.055457829260771
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.147513204	5.055457829260771
ALG11-CDG	0.14394397299999998	4.9331359196682545
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.14332982400000002	4.912088282669044
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	4.895884026183214
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	4.895884026183214
WHITE-SUTTON SYNDROME; WHSUS	0.13140643400000002	4.503459131567224
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.500925802803386
SCHINZEL-GIEDION SYNDROME	0.12959710000000002	4.441451043558725
BILATERAL POLYMICROGYRIA	0.124002104	4.249703691010659
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.067953116967683
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.049256314472737
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.042741355084136
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.110362139	3.782245416223997
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.107320054	3.6779894444634844
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.10721061000000001	3.6742386647931746
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000002	3.6587567771342413
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.106155813	3.638089482161829
16P12.1P12.3 TRIPLICATION SYNDROME	0.10515338	3.6037348778230927
AICARDI SYNDROME; AIC	0.1036867	3.553469961273519
SPINOCEREBELLAR ATAXIA TYPE 29	0.10364975400000001	3.5522037766887156
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.10310420000000001	3.53350697419377
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10224808400000002	3.50416683231091
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10224808400000002	3.50416683231091
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.10038322400000001	3.4402558004044015
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310399999999	3.3912438397477636
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.372077658590083
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.3627557489975675
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.3627557489975675
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.3627557489975675
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.3627557489975675
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.3627557489975675
CONGENITAL MYASTHENIC SYNDROME	0.093803459	3.2147592103910356
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.093803459	3.2147592103910356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.09333960000000001	3.1988621954145113
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.091474173	3.1349317317248717
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.09126560300000001	3.1277837828575357
3P25.3 MICRODELETION SYNDROME	0.09094050000000001	3.1166421056239084
UNVERRICHT-LUNDBORG DISEASE	0.0909091	3.115565989238837
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.09051070400000001	3.1019124712978523
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.08949380400000001	3.067062065183866
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08868102	3.0392069639124033
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.08867000000000001	3.038829295040955
CHROMOSOME 1P36 DELETION SYNDROME	0.087616003	3.002707529387574
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.08636980300000001	2.95999873196477
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.086236449	2.955428527365572
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	2.95357483121423
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.08528521300000001	2.9228285068028383
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08346845400000001	2.8605659549676146
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.08293227300000001	2.8421903766407355
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.082769773	2.8366213029918783
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08239085400000001	2.82363528565064
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.8150914698927316
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08184530000000001	2.804938483155695
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.081596	2.7963946673977866
BECKWITH-WIEDEMANN SYNDROME	0.08119660000000001	2.7827067411494575
3MC SYNDROME 2	0.080952174	2.774329963329792
LOCKED-IN SYNDROME	0.08020053	2.748570204599199
TRISOMY 8P	0.07951369900000001	2.725031666609549
3MC SYNDROME 3	0.07936511000000002	2.7199393399362566
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.7088937249391694
TRICHOHEPATOENTERIC SYNDROME 1	0.07872815000000001	2.698109942081635
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.07847085000000001	2.689291956544091
3MC SYNDROME	0.07750715000000001	2.656264779464684
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.654945474485076
DDOST-CDG	0.07746451900000001	2.6548037629802264
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07746451900000001	2.6548037629802264
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.6548037629802264
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.636248671990131
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.636248671990131
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.636248671990131
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.076642919	2.626646526611605
WITTEVEEN-KOLK SYNDROME	0.07659834300000001	2.6251188525994733
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.07648424000000001	2.6212084033037466
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.6152061414030645
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07378154	2.528583570375956
14Q12 MICRODELETION SYNDROME	0.07377506900000001	2.528361801295453
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.07339324000000001	2.515276054696872
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.07251557300000001	2.485197333698894
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.07251557300000001	2.485197333698894
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.07251557300000001	2.485197333698894
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.485197333698894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.466642242708798
RABIES	0.07197001900000001	2.4665005312039487
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07197001900000001	2.4665005312039487
TOXIC EPIDERMAL NECROLYSIS	0.07142860000000001	2.447945440213853
STEVENS-JOHNSON SYNDROME	0.07142860000000001	2.447945440213853
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.447945440213853
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.07142860000000001	2.447945440213853
3MC SYNDROME 1	0.07142860000000001	2.447945440213853
WALDENSTRÖM MACROGLOBULINEMIA	0.07142860000000001	2.447945440213853
ESOPHAGEAL ATRESIA	0.07142860000000001	2.447945440213853
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07142860000000001	2.447945440213853
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.447945440213853
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.070386854	2.4122435313067623
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.069565194	2.3840842386647934
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.381428424551904
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.06901964	2.3653874361698484
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06901964	2.3653874361698484
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06901964	2.3653874361698484
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.354977209637068
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.354977209637068
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0677507	2.321899311148429
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.06772852	2.321139175434388
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.3033043969978415
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.2847493060077455
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.2847493060077455
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.2847493060077455
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.2847493060077455
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.2847493060077455
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.2847493060077455
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.2847493060077455
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.2847493060077455
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.065624809	2.2490424277733996
SMITH-MAGENIS SYNDROME; SMS	0.06532929300000001	2.238914733198534
CRYPTOCOCCOSIS	0.06486894900000001	2.2231381815689373
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.221282429144248
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06295310399999998	2.157479831385585
PERLMAN SYNDROME	0.062933064	2.1567930360875973
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.1453048425237333
ACROCRANIOFACIAL DYSOSTOSIS	0.06256898000000001	2.144315432331472
PEHO SYNDROME	0.061857664	2.119937763460023
MENTAL RETARDATION, X-LINKED 98; MRX98	0.061319532999999996	2.1014953562493575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.061281213999999994	2.1001821172761233
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.060566672999999994	2.075693923712259
DOORS SYNDROME	0.059889653999999994	2.0524916549573327
HYPERTELORISM, TEEBI TYPE	0.058779	2.014428184653347
7P22.1 MICRODUPLICATION SYNDROME	0.058454094000000005	2.003293258850544
2Q23.1 MICRODUPLICATION SYNDROME	0.058454094	2.0032932588505434
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05790854	1.9845964563555987
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	1.9801196065663667
AGNATHIA-OTOCEPHALY COMPLEX	0.057360650000000006	1.965819596285
OKAMOTO SYNDROME	0.057270004	1.9627130470543888
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.057265869	1.9625713355495393
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.056642573	1.9412102196785364
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0565438	1.9378251482230373
DISTAL MONOSOMY 12Q	0.056212403999999994	1.926467802186504
17Q21.31 MICRODUPLICATION SYNDROME	0.056101154	1.9226551286884406
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.056097019000000005	1.9225134171835916
CHIME SYNDROME	0.056097019000000005	1.9225134171835916
POLAND SYNDROME	0.055555600000000004	1.9039583261934958
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.9039583261934958
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.9039583261934958
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.9039583261934958
WILDERVANCK SYNDROME	0.055555600000000004	1.9039583261934958
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.9039583261934958
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.9039583261934958
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.9039583261934958
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.9039583261934958
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.9039583261934958
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.9039583261934958
GITELMAN SYNDROME	0.055555600000000004	1.9039583261934958
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.9039583261934958
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.9039583261934958
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.9039583261934958
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.9039583261934958
SIMPSON-GOLABI-BEHMEL SYNDROME	0.055311163	1.8955811713903838
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.055087123	1.8879030467116766
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.054872624	1.8805519037664076
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05403463	1.8518328249768672
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.05398471	1.8501220055519383
ALPHA-MANNOSIDOSIS	0.053732594	1.8414816820315987
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.7540395147194905
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.050958119	1.7463970321121358
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.050795713	1.7408311799581893
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.050292604	1.7235890195003256
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.050141244	1.7184017272696122
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.049773603	1.7058022207752155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.049726704	1.7041949347133216
MONOSOMY 13Q14	0.04922214999999999	1.6869032523390108
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.6819237808012613
PYRIDOXINE-DEPENDENT EPILEPSY	0.048970853999999994	1.678291031221084
NORRIE DISEASE	0.048692619000000006	1.668755577641455
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.6641971966140034
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04826488	1.6540964392199875
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04804403	1.6465276397409099
DISTAL MONOSOMY 9P	0.048037673999999995	1.646309811850989
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.047267973000000005	1.6199312176565344
CARDIOFACIOCUTANEOUS SYNDROME	0.047023504	1.6115529661743038
16P13.11 MICRODELETION SYNDROME	0.046763203999999996	1.602632166969396
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04674574	1.6020336543404505
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.04672241900000001	1.6012344151615894
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.04672241900000001	1.6012344151615894
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04668929399999999	1.6000991809177836
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.046370323000000005	1.589167654820248
PITT-HOPKINS SYNDROME	0.046295302999999996	1.5865966277117105
NEURONAL CEROID LIPOFUSCINOSIS	0.046244349	1.5848503718427636
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.046103003999999996	1.5800063059049316
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.04607855	1.5791682374310296
ZECHI-CEIDE SYNDROME	0.045988494	1.5760819082216666
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.045984359	1.5759401967168172
FRYNS SYNDROME; FRNS	0.045984359	1.5759401967168172
HUNTINGTON DISEASE	0.045702929999999996	1.566295280852668
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.04552748	1.5602823948730253
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.04528335000000001	1.5519157613352073
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.04502774	1.543155694163611
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.5396521470920868
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.04486313399999999	1.5375144453202645
20P12.3 MICRODELETION SYNDROME	0.044856663	1.5372926762397618
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.044019719000000006	1.5086095822337986
ENDOCARDIAL FIBROELASTOSIS	0.044019719000000006	1.5086095822337986
TRISOMY 13	0.044019719000000006	1.5086095822337986
NOONAN SYNDROME	0.04385423	1.502938071901025
KLEEFSTRA SYNDROME	0.043789673	1.5007256245930296
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.043478300000000004	1.490054491243703
LAMELLAR ICHTHYOSIS	0.043478300000000004	1.490054491243703
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.043268413	1.4828614071763941
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.043244119000000004	1.4820288220980846
LISSENCEPHALY 2; LIS2	0.042790883999999994	1.4664959045889168
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.465319236437164
WEST SYNDROME	0.0426748	1.4625175640015082
ALG13-CDG	0.0426748	1.4625175640015082
VELOCARDIOFACIAL SYNDROME	0.04261387	1.4604294184173552
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.04256882	1.4588854998457796
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.042350604	1.4514069707666475
NOONAN SYNDROME 7; NS7	0.042346469000000005	1.4512652592617983
COG2-CDG	0.04221225399999999	1.4466655471400665
SARCOSINEMIA	0.04219884399999999	1.4462059700469516
TRICHOTHIODYSTROPHY	0.041856054	1.434458137701772
ISOLATED CEREBELLAR AGENESIS	0.041571448999999996	1.4247043764351077
MERRF	0.041517359999999996	1.4228506802837657
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.04122263	1.4127499228897498
ABLEPHARON-MACROSTOMIA SYNDROME	0.041164200000000005	1.4107474553617332
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.041086973	1.4081007916652388
DIENCEPHALIC SYNDROME	0.041030029999999995	1.406149285445012
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	1.406149285445012
LESCH-NYHAN SYNDROME	0.041030029999999995	1.406149285445012
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.040545554	1.3895457006751433
OCULO-PALATO-CEREBRAL SYNDROME	0.040545554	1.3895457006751433
ACROCEPHALOPOLYDACTYLY	0.04051068	1.388350526063265
MAL DE MELEDA	0.04051068	1.388350526063265
SHPRINTZEN OMPHALOCELE SYNDROME	0.04042614	1.385453236916961
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.04030501	1.3813019637410469
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.040273674	1.3802280407142127
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	1.3799838925254468
SPONDYLO-OCULAR SYNDROME	0.04	1.3708488981801983
WOLF-HIRSCHHORN SYNDROME	0.039817463000000004	1.3645931320470204
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.03938994	1.349941396209603
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.3468710373899038
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.039120539999999995	1.3407087288803592
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.03874215	1.3277408410157994
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03874215	1.3277408410157994
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.038603953999999996	1.3230046951574763
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.038595194	1.322704479248775
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.3201720415367217
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.3181226224339424
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.3181226224339424
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.3181226224339424
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.3181226224339424
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.3181226224339424
LIP, HAMARTOMATOUS	0.0384615	1.3181226224339424
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.3181226224339424
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.3181226224339424
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.3181226224339424
BAZEX SYNDROME; BZX	0.0384615	1.3181226224339424
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.3181226224339424
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.3181226224339424
CYCLIC NEUTROPENIA	0.0384615	1.3181226224339424
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.3181226224339424
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.3181226224339424
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.2983056307618492
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.288000068542445
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.037551399	1.2869323486068749
FLYNN-AIRD SYNDROME	0.037472419	1.284225607457418
ATYPICAL RETT SYNDROME	0.037472419	1.284225607457418
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.037113294	1.271917954693444
CANAVAN DISEASE	0.037037	1.2693032660475
MYOCLONUS AND ATAXIA	0.037037	1.2693032660475
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.2693032660475
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.2693032660475
MCLEOD SYNDROME; MCLDS	0.037037	1.2693032660475
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.2693032660475
CHRISTIANSON SYNDROME	0.037037	1.2693032660475
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.2693032660475
AICARDI SYNDROME	0.036931	1.2656705164673225
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.036931	1.2656705164673225
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03657568	1.253493265704788
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.036388	1.2470612426745262
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.035884189999999996	1.2297950580897221
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.035394252999999994	1.2130043181740293
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.2120224819219305
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.035171673	1.2053762294801058
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.035161549	1.2050292676239764
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.1933256794269855
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03463849	1.1871033962781454
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.034525439	1.1832290003084411
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.034182473	1.1714751362281095
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.03411333	1.1691055210939376
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.033828774	1.1593534391171734
QAZI-MARKOUIZOS SYNDROME	0.033636919	1.1527783337331645
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.142776414544707
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.033031130000000006	1.1320172041536725
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.03292872	1.1285074882621067
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.124221323554611
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.124221323554611
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.124221323554611
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.124221323554611
YOU-HOOVER-FONG SYNDROME; YHFS	0.032803653999999995	1.124221323554611
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.124079612049762
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.032799519	1.124079612049762
TUBEROUS SCLEROSIS-1	0.032799519	1.124079612049762
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.124079612049762
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.032799519	1.124079612049762
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.124079612049762
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.032799519	1.124079612049762
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.124079612049762
LEIGH SYNDROME	0.032799519	1.124079612049762
SANDHOFF DISEASE	0.032799519	1.124079612049762
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.032594934	1.117068234003907
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.1055245210596663
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.1055245210596663
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.1055245210596663
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.1055245210596663
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.031911	1.0936289797457077
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.031778879999999995	1.0891010658350182
OTOONYCHOPERONEAL SYNDROME	0.03176474	1.0886164707495118
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.031386759	1.0756625998149356
PEHO-LIKE SYNDROME; PEHOL	0.031385124	1.0756065663662224
15Q13.3 MICRODELETION SYNDROME	0.030669823000000002	1.0510923266732928
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.030622243	1.0494617019089074
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.030472209	1.044319853319168
FG SYNDROME TYPE 1	0.030379793000000002	1.0411526440248127
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.030363614	1.0405981699167213
EDINBURGH MALFORMATION SYNDROME	0.030130740000000003	1.0326172932588509
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.030059513000000003	1.0301762568970838
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.026675143082354
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.029930254000000003	1.0257463929538368
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.0182313650227903
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.029663389999999998	1.0166006374447378
11Q22.2Q22.3 MICRODELETION SYNDROME	0.029616953	1.0150091846876181
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.0079783405874088
AREDYLD	0.0294118	1.0079783405874088
OSSIFIED EAR CARTILAGES	0.0294118	1.0079783405874088
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	1.0079783405874088
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	1.0079783405874088
HAIRY EARS, Y-LINKED	0.0294118	1.0079783405874088
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	1.0079783405874088
DARWINIAN POINT OF PINNA	0.0294118	1.0079783405874088
MUSICAL PERFECT PITCH	0.0294118	1.0079783405874088
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.0079783405874088
EAR FOLDING	0.0294118	1.0079783405874088
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0294118	1.0079783405874088
OSTEOMA OF MIDDLE EAR	0.0294118	1.0079783405874088
EAR MALFORMATION	0.0294118	1.0079783405874088
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	1.0079783405874088
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.0079783405874088
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	1.0079783405874088
BLAU SYNDROME	0.0294118	1.0079783405874088
EAR WITHOUT HELIX	0.0294118	1.0079783405874088
ALKAPTONURIA	0.0294118	1.0079783405874088
EAR WAX, WET/DRY	0.0294118	1.0079783405874088
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029301532999999998	1.004199355701018
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.028886884	0.9899888275814801
CHROMOSOME 17Q12 DELETION SYNDROME	0.028832049999999998	0.9881095993694096
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.028678468999999998	0.9828461907536242
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	0.9809794715377499
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.028529854	0.9777529730285481
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	0.9712931903080985
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	0.9706759655916929
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.9706759655916929
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	0.9706759655916929
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.9706759655916929
MENKES DISEASE	0.028319219000000003	0.9705342540868436
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.027807454000000002	0.9529954419274138
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	0.9519791630967479
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.9519791630967479
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.9519791630967479
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	0.9519791630967479
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.9519791630967479
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.9519791630967479
MENINGIOMA	0.027777800000000002	0.9519791630967479
CLEFT CHIN	0.027777800000000002	0.9519791630967479
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.9519791630967479
GANGLIOCYTOMA	0.027777800000000002	0.9519791630967479
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.9519791630967479
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9519791630967479
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.9519791630967479
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.9519791630967479
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.9519791630967479
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.9519791630967479
NASAL BONES, ABSENCE OF	0.027777800000000002	0.9519791630967479
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.9519791630967479
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.9519791630967479
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.9519791630967479
DIMPLES, FACIAL	0.027777800000000002	0.9519791630967479
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.9519791630967479
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.9519791630967479
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.9519791630967479
DWARFISM, LEVI TYPE	0.027777800000000002	0.9519791630967479
OROFACIAL CLEFT 3	0.027777800000000002	0.9519791630967479
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.9519791630967479
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9519791630967479
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.9519791630967479
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	0.9519791630967479
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.9519791630967479
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9449451317728504
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	0.9448034202680011
ACROCALLOSAL SYNDROME; ACLS	0.027498869	0.9424198567462903
NIEMANN-PICK DISEASE TYPE B	0.0271205	0.9294526885774017
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9262483292779055
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	0.9262483292779055
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9262483292779055
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9262483292779055
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.027026354000000002	0.9262261900682001
COHEN SYNDROME	0.026737663000000002	0.9163323965865864
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026439254	0.90610555536516
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.026049203999999996	0.8927380650467801
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.0258937	0.8874087528702149
TEMPLE-BARAITSER SYNDROME	0.025816269000000003	0.8847550978443404
7Q11.23 MICRODUPLICATION SYNDROME	0.025513388999999997	0.8743750299873198
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.025513388999999997	0.8743750299873198
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.025253849	0.8654802769114776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.025247954000000003	0.8652782480551084
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.025243819	0.8651365365502589
PITT-HOPKINS-LIKE SYNDROME	0.025243819	0.8651365365502589
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.02497197	0.8558199389972241
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.024962793	0.8555054319887592
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.024954454	0.8552196442647111
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.024628632999999997	0.8440533602933616
RETT SYNDROME, CONGENITAL VARIANT	0.024555659	0.8415524521059669
MEHMO SYNDROME; MEHMO	0.024301243	0.8328333047739814
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.024093203	0.8257035196545461
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.024015693	0.8230471572020975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.023243814	0.7965939202851368
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0232415	0.7965146166763769
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02320945	0.7954162239967101
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.022989814	0.7878890297816925
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.022989814	0.7878890297816925
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.022900764	0.7848371774221189
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.022863704000000002	0.783567085917955
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02262717	0.775460776585901
DYSTONIA 12; DYT12	0.02261903	0.7751818088351212
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.02261903	0.7751818088351212
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.02261903	0.7751818088351212
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.022533443	0.7722486377189076
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7715550224476507
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02247053	0.7700925323006272
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.7700925323006272
BETA-UREIDOPROPIONASE DEFICIENCY	0.022456554	0.7696135576956031
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.7696135576956031
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.022456554	0.7696135576956031
ANGELMAN SYNDROME	0.022398513000000002	0.7676244216731213
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.022396883	0.7675685595805204
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.022396883	0.7675685595805204
9Q33.3Q34.11 MICRODELETION SYNDROME	0.022305499	0.7644367181877378
SMITH-MAGENIS SYNDROME	0.022150543	0.7591261866410777
SCHAAF-YANG SYNDROME; SHFYNG	0.022064723	0.756185030330032
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.022054003000000003	0.7558176428253198
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.022039853999999998	0.7553327392988108
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7528582199527057
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.021911	0.7509167552006581
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.021911	0.7509167552006581
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021873504000000002	0.7496317214435041
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.021773242999999998	0.7461956544089928
PELGER-HUET ANOMALY; PHA	0.021570044	0.73923177627746
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.021503673	0.736957160971932
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.021503673	0.736957160971932
MELAS	0.02142389	0.7342229000308443
DUPLICATION/INVERSION 15Q11	0.021384049	0.7328575002570342
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.021318604	0.7306146201034993
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.729511086740464
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.021225353000000002	0.7274187943383943
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.021073984	0.7222311936666783
MENTAL RETARDATION, X-LINKED 104; MRX104	0.020988123	0.719288632235512
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.020976349999999998	0.7188851571335549
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.7188186709619934
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02097441	0.7188186709619934
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.020962254	0.7184020699818364
MOWAT-WILSON SYNDROME; MOWS	0.020949749	0.7179735083450428
JOUBERT SYNDROME 3; JBTS3	0.020893210000000002	0.7160358476986877
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.020843524000000002	0.714333047739813
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.020843524000000002	0.714333047739813
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7108142842455191
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7108142842455191
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7108142842455191
AYMÉ-GRIPP SYNDROME	0.020722103999999998	0.7101718359093869
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.020666859000000003	0.708278522224888
DISTAL MONOSOMY 10Q	0.020447503	0.7007609239521574
PEHO SYNDROME; PEHO	0.020432243000000003	0.7002379450975018
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.020346664	0.6973050481510676
TONNE-KALSCHEUER SYNDROME; TOKAS	0.020344684000000002	0.6972371911306078
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.020015543	0.6859571267007095
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.019837003	0.6798383426436821
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.019804814	0.6787351862640942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.019804814	0.6787351862640942
FRANK-TER HAAR SYNDROME	0.01980111	0.6786082456561227
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01980111	0.6786082456561227
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.019793533	0.6783485726035848
XQ12-Q13.3 DUPLICATION SYNDROME	0.01967596	0.6743192021659413
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6743192021659413
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6716576990301245
AASE-SMITH SYNDROME I	0.01956778	0.670611741320813
SUPRABULBAR PARESIS, CONGENITAL	0.019500019	0.6682894890160733
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.019440183	0.6662388361492856
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.019299039	0.6614016587271669
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.6611117584564243
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.019240643999999998	0.659400390691936
16P11.2P12.2 MICRODELETION SYNDROME	0.019215684	0.6585449809794717
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.6582144693101204
PERMANENT NEONATAL DIABETES MELLITUS	0.019200004000000003	0.6580076082113852
TRANSIENT NEONATAL DIABETES MELLITUS	0.019200004000000003	0.6580076082113852
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.019190999	0.6576989958531821
KEPPEN-LUBINSKY SYNDROME	0.019178729	0.6572784879536654
DYSTONIA-APHONIA SYNDROME	0.019129043	0.6555756879947908
SALT-AND-PEPPER SYNDROME	0.019082104	0.6539670310839988
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.018878884	0.6470024332567943
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.018878884	0.6470024332567943
COHEN SYNDROME	0.018836309	0.6455433359607938
HSD10 DISEASE	0.018820953	0.6450170670687826
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.018820953	0.6450170670687826
DOWN SYNDROME	0.01869953	0.6408557524246891
21Q22.11Q22.12 MICRODELETION SYNDROME	0.018681349	0.6402326673292438
WEAVER SYNDROME	0.018640153	0.6388208300490079
MARSHALL-SMITH SYNDROME	0.01863731	0.6387233969635698
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6352702285890539
AMISH INFANTILE EPILEPSY SYNDROME	0.01853655	0.6352702285890539
MOEBIUS SYNDROME; MBS	0.01848961	0.6336615374070393
HYPEREKPLEXIA 4; HKPX4	0.018479873	0.6333278385139999
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.018458132999999998	0.6325827821378389
OCULOCEREBRORENAL SYNDROME OF LOWE	0.018416389	0.631152164227698
19P13.3 MICRODUPLICATION SYNDROME	0.018402144	0.6306639706638336
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.018300879	0.6271934953219782
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.018259943	0.6257905685595807
WRINKLY SKIN SYNDROME	0.018118403999999998	0.6209398540045924
WIEACKER-WOLFF SYNDROME	0.018075373	0.6194651290311526
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01801618	0.6174365125604031
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017921154	0.6141798553754414
RIN2 SYNDROME	0.01783647	0.6112776311731041
MACS SYNDROME	0.01783647	0.6112776311731041
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.017725613	0.607478426265465
2P15P16.1 MICRODELETION SYNDROME	0.017644754	0.6047072894890162
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.017595304000000003	0.603012577538641
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.017565834000000002	0.6020026046129067
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.017564923	0.6019713835292506
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.017558934	0.6017661331779705
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.017554799	0.6016244216731211
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.01740343	0.5964368210014053
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01738044	0.5956489255971762
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017263314000000002	0.5916348743959698
HYPERPROLINEMIA, TYPE I	0.017254172999999998	0.5913216011515131
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.5908838548271017
ERYTHERMALGIA, PRIMARY	0.0172414	0.5908838548271017
DIASTEMATOMYELIA	0.0172414	0.5908838548271017
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.5908838548271017
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.5908838548271017
269800 SENILE PLAQUE FORMATION	0.0172414	0.5908838548271017
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.5908838548271017
THUMBS, CONGENITAL CLASPED	0.0172414	0.5908838548271017
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.5908838548271017
PALMOMENTAL REFLEX	0.0172414	0.5908838548271017
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.5908838548271017
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.5908838548271017
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.5908838548271017
ALCOHOL DEPENDENCE	0.0172414	0.5908838548271017
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.5908838548271017
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.5908838548271017
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.5908838548271017
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.5908838548271017
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.5908838548271017
JUMPING FRENCHMAN OF MAINE	0.0172414	0.5908838548271017
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.5908838548271017
MYOPATHY, CONGENITAL	0.0172414	0.5908838548271017
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.5908838548271017
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.5908838548271017
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.5908838548271017
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.5908838548271017
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.5908838548271017
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.5908838548271017
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.5908838548271017
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.5908838548271017
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.5908838548271017
SICKLE CELL ANEMIA	0.0172414	0.5908838548271017
MOSAIC TRISOMY 15	0.0172414	0.5908838548271017
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.5908838548271017
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.5908838548271017
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.5908838548271017
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.5908838548271017
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.5908838548271017
CERVICAL RIB	0.0172414	0.5908838548271017
TRANSSEXUALITY	0.0172414	0.5908838548271017
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.5908838548271017
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.5908838548271017
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.5908838548271017
CARDIAC ARRHYTHMIA	0.0172414	0.5908838548271017
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.5908838548271017
MOTION SICKNESS	0.0172414	0.5908838548271017
RHEUMATOID ARTHRITIS	0.0172414	0.5908838548271017
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.5908838548271017
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.5908838548271017
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.5908838548271017
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.5908838548271017
VASCULAR EHLERS-DANLOS SYNDROME	0.017230494	0.5905100928750129
RAPID-ONSET DYSTONIA-PARKINSONISM	0.017180059	0.5887816237705201
SHUKLA-VERNON SYNDROME; SHUVER	0.017177723	0.5887015661948662
MICROHYDRANENCEPHALY; MHAC	0.01717029	0.588446828198362
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.01714688	0.587644538880702
MYHRE SYNDROME	0.017116413	0.5866003975461805
SPINOCEREBELLAR ATAXIA TYPE 12	0.01710526	0.5862181706021455
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.01710526	0.5862181706021455
22Q11.2 DELETION SYNDROME	0.017041193	0.5840225161931527
MUCOPOLYSACCHARIDOSIS TYPE 2	0.017033853	0.5837709654203367
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.017028923	0.583602008293636
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.017017944	0.5832257445423079
FOUNTAIN SYNDROME	0.016972239	0.5816593783200248
CRANIOFACIAL DYSSYNOSTOSIS	0.016971760000000002	0.5816429624044691
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.01694698	0.5807937215120464
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016830654	0.5768070872888037
COFFIN-LOWRY SYNDROME	0.016772499	0.5748140443469619
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.016754474	0.5741963055622195
LATHOSTEROLOSIS	0.016722549	0.5731021967853595
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.016712754	0.5727665101614176
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5727665101614176
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.016712754	0.5727665101614176
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.016702849999999998	0.572427087974228
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.01670263	0.5724195483052881
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01668494	0.5718132903800679
20P13 MICRODELETION SYNDROME	0.016629819	0.5699242263271532
SMITH-LEMLI-OPITZ SYNDROME	0.016614583	0.5694020699818363
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.016597094	0.5688027005723295
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.016594884	0.5687269611707051
FRANK-TER HAAR SYNDROME; FTHS	0.01656943	0.5678546214743481
ASPARTYLGLUCOSAMINURIA	0.016488298999999998	0.5650741629253916
ZIMMERMANN-LABAND SYNDROME 1	0.016488298999999998	0.5650741629253916
JOUBERT SYNDROME 14	0.016487504	0.5650469173035403
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.016483369	0.564905205798691
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0164686	0.5643990541142604
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.016364424	0.5608288152438399
CARTILAGE-HAIR HYPOPLASIA	0.01634628	0.5602069981836253
SOTOS SYNDROME	0.016336853000000002	0.5598839233695468
MARSHALL-SMITH SYNDROME; MRSHSS	0.016335179999999998	0.5598265876143802
GAUCHER DISEASE	0.016301509999999998	0.558672675554337
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.558672675554337
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.5583924740395491
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.016208794	0.5554951848932452
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.016171013	0.5542003838376917
ROIFMAN-CHITAYAT SYNDROME	0.016042953999999998	0.54981164536139
MOEBIUS SYNDROME	0.01603339	0.5494838753898352
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.016031419999999998	0.5494163610815999
CATEL-MANZKE SYNDROME; CATMANS	0.015999683	0.5483286952945613
WILLIAMS SYNDROME	0.01594688	0.546519071935296
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.01594688	0.546519071935296
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01578531	0.5409818705233217
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.015759873	0.5401101134377464
NON-DISTAL MONOSOMY 20Q	0.015749749	0.539763151581617
NEMALINE MYOPATHY 7; NEM7	0.015643380000000002	0.5361177559203538
SCHWARTZ-JAMPEL SYNDROME	0.01563281	0.5357555090990096
SMITH-KINGSMORE SYNDROME; SKS	0.015548539	0.5328674389115461
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5302085061174132
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.5302085061174132
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5302085061174132
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5302085061174132
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5302085061174132
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.015470953999999999	0.5302085061174132
RABSON-MENDENHALL SYNDROME	0.015462624000000001	0.5299230268343673
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.015458489	0.5297813153295179
XQ28 (MECP2) DUPLICATION	0.015372673	0.5268402961033621
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.015372673	0.5268402961033621
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.015364374	0.5265558792282122
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.015360473	0.5264221871894171
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01531211	0.5247647280578499
KOOLEN-DE VRIES SYNDROME; KDVS	0.015223872999999999	0.5217407382021317
BAKER-GORDON SYNDROME; BAGOS	0.015218454	0.5215550224476508
COFFIN-SIRIS SYNDROME 1; CSS1	0.015102033	0.517565132458275
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.015100793000000001	0.5175226361424313
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.015087123000000001	0.5170541485314782
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.015087123000000001	0.5170541485314782
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.015078888999999998	0.5167719592857878
ACROCRANIOFACIAL DYSOSTOSIS	0.01494989	0.5123510058603792
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5115117036224682
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5115117036224682
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5115117036224682
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.014923059	0.5114314746907023
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0148978	0.5105658178827239
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.0148978	0.5105658178827239
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0148978	0.5105658178827239
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.0148978	0.5105658178827239
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.014882909	0.510055485109154
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.014856662999999999	0.509156002604613
HOLMES-GANG SYNDROME	0.014831254	0.5082852051132665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.014831254	0.5082852051132665
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.5082852051132665
TURNPENNY-FRY SYNDROME; TPFS	0.014831254	0.5082852051132665
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.014827119	0.5081434936084172
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01476438	0.5059933513828438
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.014742553999999998	0.5052453476815518
WIEDEMANN-STEINER SYNDROME	0.014701159	0.5038266904280476
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.014688443	0.5033908975633162
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.014652279	0.5021515130744715
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.014565403000000001	0.49917416635251394
20Q11.2 MICRODUPLICATION SYNDROME	0.014565403000000001	0.49917416635251394
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.014545704000000001	0.4984990575413827
OGDEN SYNDROME	0.014545704000000001	0.4984990575413827
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.014541569	0.49835734603653326
ARGININEMIA	0.014531803	0.49802265327804246
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.014531803	0.49802265327804246
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.014529763999999999	0.4979527742554578
HURLER SYNDROME	0.014527794	0.49788525994722244
MONOSOMY 18Q	0.014523293000000001	0.49773100517495467
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.014477714	0.4961689571267008
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.014414460000000002	0.49400116522156357
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0144089	0.4938106172247165
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.014399783999999999	0.4934982007608212
COFFIN-SIRIS SYNDROME 7; CSS7	0.014399783999999999	0.4934982007608212
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.014311109	0.49045920010966804
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.0142857	0.4895884026183215
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0142857	0.4895884026183215
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.4895884026183215
INFANT BOTULISM	0.0142857	0.4895884026183215
CHILDHOOD APRAXIA OF SPEECH	0.0142857	0.4895884026183215
ALLAN-HERNDON-DUDLEY SYNDROME	0.0142857	0.4895884026183215
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0142857	0.4895884026183215
WILSON DISEASE	0.0142857	0.4895884026183215
NEUROLEPTIC MALIGNANT SYNDROME	0.0142857	0.4895884026183215
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.014268114	0.4889857089002365
FOCAL DERMAL HYPOPLASIA; FDH	0.01425919	0.4886798725110526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.48816457041022654
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.48816457041022654
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.014142889	0.48469409506837113
RAINE SYNDROME	0.014108524	0.48351636450872215
HALLERMANN-STREIFF SYNDROME; HSS	0.01405563	0.4817036224682135
FONTAINE PROGEROID SYNDROME; FPS	0.014015060000000001	0.48031323897323425
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.014004494	0.47995112923677996
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014004494	0.47995112923677996
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.014000150000000001	0.47980225504643764
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.013989699000000001	0.47944408650056564
NEUROCUTANEOUS MELANOCYTOSIS	0.013986249000000001	0.47932585078309753
ANGELMAN SYNDROME	0.013986249	0.47932585078309753
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.013986249	0.47932585078309753
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01398224	0.4791884574522774
NANCE-HORAN SYNDROME	0.013980260000000001	0.47912060043181753
KEIPERT SYNDROME	0.013980260000000001	0.47912060043181753
CARNOSINASE DEFICIENCY	0.013932159999999999	0.4774721546317558
RING CHROMOSOME 14 SYNDROME	0.013844904	0.47448178484526554
LISSENCEPHALY 8; LIS8	0.013789672999999999	0.47258895095788067
PITT-HOPKINS SYNDROME	0.013787569	0.47251684430583646
15Q26 OVERGROWTH SYNDROME	0.013755380000000001	0.4714136879262485
PHELAN-MCDERMID SYNDROME	0.013737883	0.4708140443469619
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.01372256	0.4702889064052916
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.4694677679152816
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.4694677679152816
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.4694677679152816
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.4694677679152816
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.4694677679152816
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.013660819000000001	0.468172966859728
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013628593000000001	0.46706854244490914
MENKES DISEASE	0.013586849	0.46563792453476827
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.013468313	0.46157555090990104
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.013439913000000001	0.46060224819219314
MONOSOMY 18P	0.013331304	0.45688008499263183
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.013328354	0.45677898488639096
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.013307183	0.45605342883580663
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.013307183	0.45605342883580663
DESMOSTEROLOSIS	0.01329935	0.4557849823503205
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.013296983	0.45570386236677074
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.013282073	0.4551928784399741
MENTAL RETARDATION, X-LINKED 9	0.013282073	0.4551928784399741
INFANTILE LIVER FAILURE SYNDROME 1	0.013282073	0.4551928784399741
KRABBE DISEASE	0.013253094	0.45419973268446495
SCARF SYNDROME	0.01325152	0.4541457897803215
LAMB-SHAFFER SYNDROME	0.013243814000000001	0.45388169574008713
GERMAN SYNDROME	0.013243814000000001	0.45388169574008713
KLEEFSTRA SYNDROME	0.013229809	0.4534017272696118
1P36 DELETION SYNDROME	0.013221973000000001	0.4531331779704583
WILLIAMS-BEUREN SYNDROME; WBS	0.01320207	0.4524510778299463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.013051613	0.44729473251310886
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.013051613	0.44729473251310886
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.013051613	0.44729473251310886
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.013051613	0.44729473251310886
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.013048932999999999	0.4472028856369307
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.01299215	0.44525686281229654
ACRODYSOSTOSIS	0.01294239	0.4435515267829604
PFEIFFER SYNDROME	0.01294239	0.4435515267829604
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.012892023	0.44182538812159433
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.012892023	0.44182538812159433
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.012892023	0.44182538812159433
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.012880049	0.4414150245039241
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012844893	0.44021018540731355
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01284347	0.4401614174577607
6Q25 MICRODELETION SYNDROME	0.012793173000000001	0.43843767778196663
AL KAISSI SYNDROME; ALKAS	0.012793173000000001	0.43843767778196663
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01278575	0.4381832824976868
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012761629	0.4373566263408617
FAMILIAL DYSAUTONOMIA	0.012761629	0.4373566263408617
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.012761629	0.4373566263408617
METACHROMATIC LEUKODYSTROPHY	0.012761629	0.4373566263408617
PELIZAEUS-MERZBACHER DISEASE	0.012761629	0.4373566263408617
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.012755564	0.43714877137667507
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.012740654	0.43663778744987847
GALACTOSE EPIMERASE DEFICIENCY	0.012740654	0.43663778744987847
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.012740654	0.43663778744987847
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.012740654	0.43663778744987847
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.012740654	0.43663778744987847
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.012740654	0.43663778744987847
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.012736519	0.43649607594502904
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.012736519	0.43649607594502904
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.012736519	0.43649607594502904
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.012736519	0.43649607594502904
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.012736519	0.43649607594502904
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.012736519	0.43649607594502904
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.012736519	0.43649607594502904
DILATED CARDIOMYOPATHY WITH ATAXIA	0.012736519	0.43649607594502904
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.012736519	0.43649607594502904
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.012736519	0.43649607594502904
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.012736519	0.43649607594502904
GAUCHER DISEASE TYPE 3	0.01270754	0.43550293018951997
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0127027	0.4353370574728402
KNIEST-LIKE DYSPLASIA, LETHAL	0.01268839	0.43484663627951614
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.012609410000000001	0.43213989513005946
LATHOSTEROLOSIS	0.012600763000000001	0.4318435518694953
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.43117560574385694
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012561603000000001	0.4305014907981769
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.012510194	0.4287396415230132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012506059	0.42859793001816376
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.012495884	0.4282492203296893
PRIMARY DYSTONIA, DYT4 TYPE	0.01237685	0.4241697796360397
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.01235294	0.4233503547071525
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.012350604000000001	0.42327029713149883
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.012350604000000001	0.42327029713149883
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.012323029	0.42232526817231575
GENITOPATELLAR SYNDROME; GTPTS	0.012310814	0.42190664519003396
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.012299339	0.42151338291236856
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.012260704	0.4201893142328388
NEUROFERRITINOPATHY	0.01222021	0.41880153535076603
ADULT POLYGLUCOSAN BODY DISEASE	0.01222021	0.41880153535076603
ABETA AMYLOIDOSIS, IOWA TYPE	0.01222021	0.41880153535076603
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01222021	0.41880153535076603
SPINOCEREBELLAR ATAXIA TYPE 17	0.01222021	0.41880153535076603
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.01222021	0.41880153535076603
RHEUMATIC FEVER	0.01222021	0.41880153535076603
CORTICOBASAL SYNDROME	0.01222021	0.41880153535076603
HENNEKAM SYNDROME	0.012214799	0.41861609376606473
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0121951	0.41794098495493337
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0121951	0.41794098495493337
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0121951	0.41794098495493337
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0121951	0.41794098495493337
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0121951	0.41794098495493337
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0121951	0.41794098495493337
RAMOS-ARROYO SYNDROME	0.0121951	0.41794098495493337
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.0121951	0.41794098495493337
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0121951	0.41794098495493337
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.0121951	0.41794098495493337
CLASSIC MULTIMINICORE MYOPATHY	0.0121951	0.41794098495493337
JOUBERT SYNDROME 4	0.0121951	0.41794098495493337
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0121951	0.41794098495493337
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.0121951	0.41794098495493337
MEIER-GORLIN SYNDROME 3; MGORS3	0.01206902	0.4136200692278694
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.4126205147537613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.4126205147537613
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4126205147537613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.4126205147537613
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.4126205147537613
FUMARASE DEFICIENCY; FMRD	0.012039854	0.4126205147537613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.4126205147537613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.4126205147537613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.4126205147537613
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.4126205147537613
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.4126205147537613
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.4126205147537613
COHEN-GIBSON SYNDROME; COGIS	0.012037024	0.4125235271942151
1Q41Q42 MICRODELETION SYNDROME	0.012016049000000001	0.41180468830323186
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011980183	0.41057551663867853
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01195033	0.4095524178347442
COCKAYNE SYNDROME A; CSA	0.011926209	0.40872576167791913
GAPO SYNDROME; GAPOS	0.011840759	0.40579728571918167
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.011822929	0.4051862298228178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.011820593	0.40510617224716416
GABRIELE-DE VRIES SYNDROME	0.011805050000000001	0.4045734946365538
OROFACIODIGITAL SYNDROME TYPE 6	0.011792763000000001	0.40415240412625525
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011773243	0.40348342986394325
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.011769454	0.4033535762020632
BENT BONE DYSPLASIA SYNDROME; BBDS	0.01175792	0.40295829192227295
FGFR2-RELATED BENT BONE DYSPLASIA	0.01175792	0.40295829192227295
INFANTILE SYSTEMIC HYALINOSIS	0.01175792	0.40295829192227295
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01171515	0.4014925117378938
MOSAIC TRISOMY 1	0.011706200000000002	0.40118578429692603
CRI-DU-CHAT SYNDROME	0.011706200000000002	0.40118578429692603
CHROMOSOME 18Q DELETION SYNDROME	0.011675609	0.40013739333082016
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01167338	0.4000610027759691
SNEDDON SYNDROME	0.011666289	0.39981798553754416
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011663953000000001	0.3997379279618905
TRISOMY 20P	0.01157601	0.39672401384557393
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.011513790000000001	0.3945916583844547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.3942449364268824
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.011503673	0.3942449364268824
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.011503673	0.3942449364268824
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.011503673	0.3942449364268824
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.011503673	0.3942449364268824
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.011503673	0.3942449364268824
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.3942449364268824
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.011503673	0.3942449364268824
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.011503673	0.3942449364268824
6Q TERMINAL DELETION SYNDROME	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.3939237122588163
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.3939237122588163
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.3939237122588163
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.3939237122588163
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.3939237122588163
MOWAT-WILSON SYNDROME	0.011434629	0.3918787141437336
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.38954947050961314
RING CHROMOSOME 7 SYNDROME	0.01133096	0.3883258507830975
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.011292869	0.38702042564858297
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01128151	0.3866311388327222
AU-KLINE SYNDROME; AUKS	0.011279174000000001	0.38655108125706855
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.011277989	0.38651046985845994
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.011275039	0.3864093697522191
COFFIN-LOWRY SYNDROME; CLS	0.011275039	0.3864093697522191
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.011227688999999999	0.38478662736899827
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.011225353	0.3847065697933446
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0112239	0.3846567737071182
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.011184764	0.3833155351451387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.011184764	0.3833155351451387
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.011180629000000001	0.38317382364028935
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.01112487	0.3812628945474486
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.011086973	0.3799641180300902
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.011086973	0.3799641180300902
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.011086973	0.3799641180300902
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.011086973	0.3799641180300902
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.011086973	0.3799641180300902
COFFIN-SIRIS SYNDROME 2; CSS2	0.011072663	0.37947369683676624
GIANT AXONAL NEUROPATHY	0.011036029999999999	0.37821823914459035
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0110272	0.37791562425031705
3Q29 MICRODELETION SYNDROME	0.011007214000000001	0.3772306795983414
HEART AND BRAIN MALFORMATION SYNDROME	0.010988123	0.3765764076904624
SHORT RIB-POLYDACTYLY SYNDROME	0.01097775	0.37622091229994176
KBG SYNDROME	0.010968203	0.3758937249391686
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.010958119	0.3755481339319374
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.3755481339319374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010958119	0.3755481339319374
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.010958119	0.3755481339319374
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.010958119	0.3755481339319374
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.010958119	0.3755481339319374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.3755481339319374
DEND SYNDROME	0.010958119	0.3755481339319374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.3755481339319374
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.3755481339319374
XYLOSIDASE DEFICIENCY	0.010958119	0.3755481339319374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.3755481339319374
SLC39A8-CDG	0.010958119	0.3755481339319374
AL-RAQAD SYNDROME; ARS	0.010928064	0.37451811234106724
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010828533000000001	0.371107063298948
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.010828533000000001	0.371107063298948
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010803053	0.3702338325508071
GLASS SYNDROME	0.010803053	0.3702338325508071
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010795713	0.3699822817779911
RECOMBINANT 8 SYNDROME	0.010795713	0.3699822817779911
RECOMBINANT CHROMOSOME 8 SYNDROME	0.010795713	0.3699822817779911
INFANTILE SIALIC ACID STORAGE DISEASE	0.010795713	0.3699822817779911
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01074589	0.36827478666164026
PROTEUS SYNDROME	0.010733620000000001	0.36785427876212357
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.01068627	0.3662315363789027
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.01068627	0.3662315363789027
DYSTONIA 16	0.01068627	0.3662315363789027
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.01068627	0.3662315363789027
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.01068627	0.3662315363789027
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.01068627	0.3662315363789027
AASE-SMITH SYNDROME	0.01063921	0.3646187326501937
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01063921	0.3646187326501937
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01063921	0.3646187326501937
HYDROLETHALUS SYNDROME 1	0.01063921	0.3646187326501937
CRANIOFRONTONASAL SYNDROME; CFNS	0.010637924	0.3645746598581172
AARSKOG-SCOTT SYNDROME	0.010637924	0.3645746598581172
SIALIDOSIS TYPE 1	0.010627239	0.3642084718461908
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.010545554	0.36140902703999456
POPOV-CHANG SYNDROME; POPCHAS	0.010545554	0.36140902703999456
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.010545554	0.36140902703999456
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.010545554	0.36140902703999456
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.010545554	0.36140902703999456
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.010545554	0.36140902703999456
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.010545554	0.36140902703999456
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.010545554	0.36140902703999456
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010531244	0.3609186058466706
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.010527109	0.36077689434182125
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01049053	0.35952328729565786
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.01049053	0.35952328729565786
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01049053	0.35952328729565786
CHROMOSOME 16Q22 DELETION SYNDROME	0.010446704000000001	0.3580213167003668
CHROMOSOME 9P DELETION SYNDROME	0.010446704000000001	0.3580213167003668
6Q16 MICRODELETION SYNDROME	0.010426784	0.357338633949073
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.010416700000000001	0.3569930429418418
OCULODENTODIGITAL DYSPLASIA	0.010312379	0.3534178347441654
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01028945	0.35263202988450604
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01028945	0.35263202988450604
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.010287114000000002	0.3525519723088524
OTOPALATODIGITAL SYNDROME TYPE 2	0.010287114000000002	0.3525519723088524
GABRIELE-DE VRIES SYNDROME; GADEVS	0.010287114000000002	0.3525519723088524
SECKEL SYNDROME 1; SCKL1	0.010282979000000001	0.35241026080400295
2Q32Q33 MICRODELETION SYNDROME	0.010261633999999999	0.35167874156071144
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.010254294	0.35142719078789547
LIGNEOUS CONJUNCTIVITIS	0.010254294	0.35142719078789547
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.010254294	0.35142719078789547
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.010250159	0.3512854792830461
C SYNDROME	0.010250159	0.3512854792830461
GM1 GANGLIOSIDOSIS	0.010250159	0.3512854792830461
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.010250159	0.3512854792830461
STURGE-WEBER SYNDROME	0.010250159	0.3512854792830461
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010149532999999999	0.34783690325233907
ACROOSTEOLYSIS DOMINANT TYPE	0.01009237	0.3458778573631722
15Q24 MICRODELETION SYNDROME	0.010064993	0.34493961410603524
FILIPPI SYNDROME	0.010064993	0.34493961410603524
8P23.1 MICRODELETION SYNDROME	0.010064993	0.34493961410603524
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.010033373	0.3438559580520238
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.010015543	0.34324490215565995
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.010015543	0.34324490215565995
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010015543	0.34324490215565995
PRADER-WILLI-LIKE SYNDROME	0.010015543	0.34324490215565995
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.010015543	0.34324490215565995
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.010015543	0.34324490215565995
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.010015543	0.34324490215565995
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.010015543	0.34324490215565995
BETHLEM MYOPATHY 2; BTHLM2	0.01	0.34271222454504957
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01	0.34271222454504957
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.01	0.34271222454504957
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.01	0.34271222454504957
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.01	0.34271222454504957
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.01	0.34271222454504957
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.01	0.34271222454504957
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.01	0.34271222454504957
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.01	0.34271222454504957
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.01	0.34271222454504957
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.01	0.34271222454504957
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.01	0.34271222454504957
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.01	0.34271222454504957
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.01	0.34271222454504957
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.01	0.34271222454504957
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00998569	0.3422218033517256
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00998569	0.3422218033517256
PELVISCAPULAR DYSPLASIA	0.00998569	0.3422218033517256
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00998569	0.3422218033517256
KEIPERT SYNDROME; KPTS	0.00998569	0.3422218033517256
SIMOSA CRANIOFACIAL SYNDROME	0.009901150000000001	0.33932451420542176
TRISOMY 18P	0.009901150000000001	0.33932451420542176
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.009901150000000001	0.33932451420542176
BARBER-SAY SYNDROME	0.009901150000000001	0.33932451420542176
TRISOMY 18-LIKE SYNDROME	0.009901150000000001	0.33932451420542176
BRANCHIO-OCULO-FACIAL SYNDROME	0.009901150000000001	0.33932451420542176
TETRASOMY 9P	0.009868222999999999	0.3381960656636622
MENTAL RETARDATION, X-LINKED 90	0.009858903	0.3378766578703863
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009858903	0.3378766578703863
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009858903	0.3378766578703863
HEREDITARY FOLATE MALABSORPTION	0.009858903	0.3378766578703863
INFANTILE REFSUM DISEASE	0.009858903	0.3378766578703863
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3360229617190446
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3360229617190446
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3360229617190446
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3360229617190446
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3360229617190446
BIOTINIDASE DEFICIENCY	0.009804814	0.3360229617190446
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3358812502141952
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3358812502141952
JOUBERT SYNDROME WITH OCULAR DEFECT	0.009743583	0.3339245004969328
JOUBERT SYNDROME	0.009743583	0.3339245004969328
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.009743583	0.3339245004969328
JOUBERT SYNDROME WITH RENAL DEFECT	0.009743583	0.3339245004969328
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.009741560000000002	0.3338551698139074
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.009741560000000002	0.3338551698139074
MAXILLOFACIAL DYSOSTOSIS	0.009741560000000002	0.3338551698139074
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009716079999999998	0.3329819390657665
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.009716079999999998	0.3329819390657665
HEREDITARY GINGIVAL FIBROMATOSIS	0.00970874	0.3327303882929505
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.00970874	0.3327303882929505
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00970874	0.3327303882929505
DERMOCHONDROCORNEAL DYSTROPHY	0.00970874	0.3327303882929505
ACUTE PROMYELOCYTIC LEUKEMIA	0.00970874	0.3327303882929505
ENAMEL-RENAL SYNDROME	0.00970874	0.3327303882929505
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00970874	0.3327303882929505
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00970874	0.3327303882929505
OTODENTAL SYNDROME	0.00970874	0.3327303882929505
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00970874	0.3327303882929505
JUVENILE HYALINE FIBROMATOSIS	0.00970874	0.3327303882929505
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00970874	0.3327303882929505
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00970874	0.3327303882929505
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00970874	0.3327303882929505
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00970874	0.3327303882929505
H SYNDROME	0.00970874	0.3327303882929505
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00970874	0.3327303882929505
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00970874	0.3327303882929505
HYPOPLASMINOGENEMIA	0.00970874	0.3327303882929505
OROFACIODIGITAL SYNDROME TYPE 2	0.009552444	0.32737393330820114
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00952683	0.32649611021625147
GOLDBERG-SHPRINTZEN SYNDROME	0.009523574	0.3263845231159396
FAMILIAL VISCERAL MYOPATHY	0.00948183	0.32495390520579875
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.009474124	0.32468981116556433
MENTAL RETARDATION, X-LINKED 106; MRX106	0.009474124	0.32468981116556433
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009474124	0.32468981116556433
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.009474124	0.32468981116556433
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.009469989	0.32454809966071496
5Q14.3 MICRODELETION SYNDROME	0.009469989	0.32454809966071496
2Q23.1 MICRODELETION SYNDROME	0.009469989	0.32454809966071496
POSTENCEPHALITIC PARKINSONISM	0.009469989	0.32454809966071496
MENTAL RETARDATION, X-LINKED 21	0.009469989	0.32454809966071496
GAUCHER DISEASE, PERINATAL LETHAL	0.009469989	0.32454809966071496
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009420303	0.3228452997018404
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.009420303	0.3228452997018404
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.009420303	0.3228452997018404
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.009420303	0.3228452997018404
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009420303	0.3228452997018404
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.009420303	0.3228452997018404
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.009420303	0.3228452997018404
N-ACETYLASPARTATE DEFICIENCY; NACED	0.009420303	0.3228452997018404
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.009420303	0.3228452997018404
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.009420303	0.3228452997018404
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00939519	0.32198464649234043
W SYNDROME	0.009392854	0.3219045889166868
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.009366749	0.3210099386545119
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00932914	0.3197210322492204
DE BARSY SYNDROME	0.009326804	0.3196409746735666
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.31932156688029073
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.31932156688029073
FETAL ALCOHOL SYNDROME	0.009317484000000001	0.31932156688029073
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.31932156688029073
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009313349	0.3191798553754413
5Q35 MICRODUPLICATION SYNDROME	0.009313349	0.3191798553754413
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.3191798553754413
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.3191798553754413
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.009313349	0.3191798553754413
CORNELIA DE LANGE SYNDROME 1	0.009313349	0.3191798553754413
PINEOBLASTOMA	0.009313349	0.3191798553754413
SCLERODERMA	0.009313349	0.3191798553754413
2Q33.1 DELETION SYNDROME	0.009313349	0.3191798553754413
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.3191798553754413
L-2-HYDROXYGLUTARIC ACIDURIA	0.009313349	0.3191798553754413
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.3191798553754413
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.31732615922409957
GAUCHER DISEASE TYPE 2	0.00925926	0.31732615922409957
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.31732615922409957
CARNOSINEMIA	0.00925926	0.31732615922409957
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.31732615922409957
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.31732615922409957
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.31732615922409957
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.31732615922409957
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.31732615922409957
PAINE SYNDROME	0.00925926	0.31732615922409957
HYDROXYLYSINURIA	0.00925926	0.31732615922409957
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.31732615922409957
608028 THAI SYMPHALANGISM SYNDROME	0.00922215	0.3160543541588129
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.009222149999999998	0.31605435415881283
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.009208153	0.3155746598581172
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.009208153	0.3155746598581172
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.009202164	0.3153694095068372
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.009198029	0.3152276980019878
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.009130163	0.31290184721889036
DISTAL TRISOMY 5Q	0.00906256	0.3105850097672985
CARPENTER SYNDROME	0.00902538	0.30931080571643993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.009023483	0.3092457932074438
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.009023483	0.3092457932074438
DESANTO-SHINAWI SYNDROME	0.009023483	0.3092457932074438
GENITOPATELLAR SYNDROME	0.008998003	0.30837256245930295
ZLOTOGORA-OGUR SYNDROME	0.008984009000000001	0.3078929709722747
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00892857	0.30599300867061935
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00892857	0.30599300867061935
ALLAN-HERNDON-DUDLEY SYNDROME	0.00892857	0.30599300867061935
MONOSOMY 22	0.00892857	0.30599300867061935
PEROXISOME BIOGENESIS DISORDER 5B	0.008878884	0.3042902087117448
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.008878884	0.3042902087117448
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.008878884	0.3042902087117448
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.008878884	0.3042902087117448
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.008878884	0.3042902087117448
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.008878884	0.3042902087117448
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.008878884	0.3042902087117448
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.008878884	0.3042902087117448
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.008878884	0.3042902087117448
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.008874749	0.3041484972068954
CEREBELLOPARENCHYMAL DISORDER II	0.008874749	0.3041484972068954
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.008874749	0.3041484972068954
INCONTINENTIA PIGMENTI	0.008808752999999999	0.3018867336097879
BREATH-HOLDING SPELLS	0.00877193	0.30062476438534574
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.30062476438534574
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.30062476438534574
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.30062476438534574
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.30062476438534574
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.30062476438534574
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.30062476438534574
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00877193	0.30062476438534574
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.30062476438534574
HISTIDINEMIA	0.00877193	0.30062476438534574
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.30062476438534574
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.30062476438534574
MILROY DISEASE	0.00877193	0.30062476438534574
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.30062476438534574
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.30062476438534574
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.30062476438534574
HISTIDINEMIA	0.00877193	0.30062476438534574
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.30062476438534574
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.30062476438534574
CAFFEY DISEASE	0.00877193	0.30062476438534574
ALEXANDER DISEASE	0.008662599	0.2968778573631722
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.008662599	0.2968778573631722
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.008662599	0.2968778573631722
PARTINGTON SYNDROME	0.008662599	0.2968778573631722
CADASIL	0.008662599	0.2968778573631722
MUSCLE-EYE-BRAIN DISEASE	0.008662599	0.2968778573631722
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008648243	0.2963858596936153
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00859108	0.2944268138044484
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008588743999999999	0.2943467562287947
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.008588743999999999	0.2943467562287947
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.008584609	0.2942050447239454
BARTH SYNDROME; BTHS	0.00850392	0.2914397340553138
MELNICK-NEEDLES SYNDROME	0.00850392	0.2914397340553138
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.29069070221734816
FETAL HYDANTOIN SYNDROME	0.008482064000000001	0.29069070221734816
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.008482064000000001	0.29069070221734816
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008482064000000001	0.29069070221734816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.008477929	0.2905489907124988
OCULODENTODIGITAL DYSPLASIA; ODDD	0.008477929	0.2905489907124988
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008477929	0.2905489907124988
MECKEL SYNDROME, TYPE 10; MKS10	0.008477929	0.2905489907124988
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.008477929	0.2905489907124988
BARAITSER-WINTER SYNDROME 2; BRWS2	0.008477929	0.2905489907124988
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.008477929	0.2905489907124988
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.008452448999999999	0.28967575996435796
LATERAL MENINGOCELE SYNDROME	0.00843149	0.28895746941293404
MEIER-GORLIN SYNDROME 6; MGORS6	0.00843149	0.28895746941293404
WOLCOTT-RALLISON SYNDROME	0.008391819	0.28759789574694133
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.008344483	0.2859756331608349
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.008344483	0.2859756331608349
CORNELIA DE LANGE SYNDROME 3	0.008344483	0.2859756331608349
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.00833333	0.2855934062167998
DEAFNESS, X-LINKED 5; DFNX5	0.00833333	0.2855934062167998
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00833333	0.2855934062167998
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA 41; SCA41	0.00833333	0.2855934062167998
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00833333	0.2855934062167998
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.00833333	0.2855934062167998
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00833333	0.2855934062167998
HUNTINGTON DISEASE-LIKE 1	0.00833333	0.2855934062167998
SYDENHAM CHOREA	0.00833333	0.2855934062167998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00833333	0.2855934062167998
VERVERI-BRADY SYNDROME; VERBRAS	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA TYPE 43	0.00833333	0.2855934062167998
CHIARI MALFORMATION TYPE I	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA TYPE 40	0.00833333	0.2855934062167998
PROGRESSIVE SUPRANUCLEAR PALSY	0.00833333	0.2855934062167998
PLAGUE	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA TYPE 6	0.00833333	0.2855934062167998
ATAXIA-PANCYTOPENIA SYNDROME	0.00833333	0.2855934062167998
SYRINGOMYELIA, ISOLATED	0.00833333	0.2855934062167998
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.00833333	0.2855934062167998
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.00833333	0.2855934062167998
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA TYPE 8	0.00833333	0.2855934062167998
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00833333	0.2855934062167998
KURU, SUSCEPTIBILITY TO	0.00833333	0.2855934062167998
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.00833333	0.2855934062167998
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00833333	0.2855934062167998
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.00833333	0.2855934062167998
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00833333	0.2855934062167998
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.00833333	0.2855934062167998
MYXOPAPILLARY EPENDYMOMA	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA 42	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00833333	0.2855934062167998
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA 40; SCA40	0.00833333	0.2855934062167998
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00833333	0.2855934062167998
CRANIOFACIOFRONTODIGITAL SYNDROME	0.008287319999999999	0.284016587271668
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.008287319999999999	0.284016587271668
HEREDITARY HYPEREKPLEXIA	0.008263198999999999	0.28318993111484286
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.008259942999999999	0.28307834401453097
MOSAIC TRISOMY 14	0.008259942999999999	0.28307834401453097
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.008259942999999999	0.28307834401453097
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.008259942999999999	0.28307834401453097
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008259942999999999	0.28307834401453097
KOOLEN-DE VRIES SYNDROME	0.008259942999999999	0.28307834401453097
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008259942999999999	0.28307834401453097
MESOMELIA-SYNOSTOSES SYNDROME	0.00812773	0.2785472428801536
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00812773	0.2785472428801536
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00812118	0.27832276637307657
MUCOLIPIDOSIS TYPE IV	0.00812118	0.27832276637307657
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.008112813	0.27803601905479974
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.008100353	0.2776089996230166
CEDNIK SYNDROME	0.008100353	0.2776089996230166
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.008063173	0.2763347955721581
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.008063173	0.2763347955721581
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.008043189999999999	0.2756499537338497
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.008043189999999999	0.2756499537338497
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.008043189999999999	0.2756499537338497
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.00793651	0.2719938997224032
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00793651	0.2719938997224032
BRANCHIOOTIC SYNDROME 2	0.00793651	0.2719938997224032
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.2719938997224032
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00793651	0.2719938997224032
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.2719938997224032
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00793651	0.2719938997224032
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00793651	0.2719938997224032
VAN BOGAERT-HOZAY SYNDROME	0.00793651	0.2719938997224032
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.2719938997224032
FIBROCHONDROGENESIS 1; FBCG1	0.00793651	0.2719938997224032
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.2719938997224032
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.2719938997224032
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00793651	0.2719938997224032
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00793651	0.2719938997224032
RESTRICTIVE DERMOPATHY, LETHAL	0.00793651	0.2719938997224032
WOLFRAM-LIKE SYNDROME	0.00793651	0.2719938997224032
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00793651	0.2719938997224032
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.2719938997224032
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00793651	0.2719938997224032
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00793651	0.2719938997224032
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.2719938997224032
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.2719938997224032
184705 STEINFELD SYNDROME	0.00793651	0.2719938997224032
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00793651	0.2719938997224032
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.2719938997224032
KENNERKNECHT SYNDROME	0.00793651	0.2719938997224032
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.2719938997224032
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.2719938997224032
MEHMO SYNDROME	0.007917018999999999	0.27132591932554234
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00791103	0.27112066897426235
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00791103	0.27112066897426235
DUANE RETRACTION SYNDROME	0.007803493	0.26743524452517226
PSEUDOAMINOPTERIN SYNDROME	0.007803063999999999	0.26742054217073924
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.007803063999999999	0.26742054217073924
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.007803063999999999	0.26742054217073924
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.007798929	0.2672788306658899
SAETHRE-CHOTZEN SYNDROME	0.007798929	0.2672788306658899
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0077245130000000006	0.26472850337571546
BRITTLE CORNEA SYNDROME 2; BCS2	0.007721779999999999	0.26463484012474725
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.007721779999999999	0.26463484012474725
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.007721779999999999	0.26463484012474725
OSTEOGENESIS IMPERFECTA	0.007721779999999999	0.26463484012474725
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.007718524	0.26452325302443547
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.007714389	0.26438154151958604
LISSENCEPHALY, X-LINKED, 2	0.007714389	0.26438154151958604
TEMTAMY SYNDROME; TEMTYS	0.007643903	0.2619659001336578
1Q44 MICRODELETION SYNDROME	0.007587804	0.2600433188251825
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.2600433188251825
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2600433188251825
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2600433188251825
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.2600433188251825
X SMALL RINGS	0.007587804	0.2600433188251825
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.2600433188251825
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.2600433188251825
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.25990160732033313
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.25990160732033313
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.007567259	0.25933921655985476
POTOCKI-LUPSKI SYNDROME	0.007564923	0.25925915898420104
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.007561699	0.25914866856300767
CHROMOSOME 17P13.1 DELETION SYNDROME	0.007558934	0.25905390863292094
MONOSOMY 13Q34	0.007558934	0.25905390863292094
HYPERTRICHOSIS CUBITI	0.007558934	0.25905390863292094
DISTAL TRISOMY 15Q	0.007554799	0.2589121971280716
MULTIPLE METAPHYSEAL DYSPLASIA	0.007462099999999999	0.25573528907776144
NON-DISTAL MONOSOMY 10Q	0.007462099999999999	0.25573528907776144
2Q37 MICRODELETION SYNDROME	0.0074096529999999996	0.25393786627369
PETERS-PLUS SYNDROME; PTRPLS	0.0074096529999999996	0.25393786627369
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.007406244	0.2538210356763426
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007406244	0.2538210356763426
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.007402109	0.25367932417149325
MONOSOMY 22Q13.3	0.007325112999999999	0.25104057712738614
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.007325112999999999	0.25104057712738614
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.007325112999999999	0.25104057712738614
CINCA SYNDROME	0.007267634	0.24907070153192368
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.007263499	0.2489289900270743
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.007263499	0.2489289900270743
ADAMS-OLIVER SYNDROME	0.007263499	0.2489289900270743
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.007262074	0.24888015353507664
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00725751	0.24872373967579428
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00725751	0.24872373967579428
URBAN-ROGERS-MEYER SYNDROME	0.00725751	0.24872373967579428
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00725751	0.24872373967579428
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.007237953	0.2480534973782515
NEONATAL ADRENOLEUKODYSTROPHY	0.007178959	0.24603170088077048
ZELLWEGER SYNDROME	0.007178959	0.24603170088077048
ADULT SYNDROME	0.00717297	0.24582645052949043
600736 VELOFACIOSKELETAL SYNDROME	0.00717297	0.24582645052949043
WAARDENBURG SYNDROME	0.00717297	0.24582645052949043
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00717297	0.24582645052949043
WAARDENBURG-SHAH SYNDROME	0.00717297	0.24582645052949043
STROMME SYNDROME; STROMS	0.00717297	0.24582645052949043
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.007171993999999999	0.24579300181637478
MONOSOMY 9Q22.3	0.007165523	0.24557123273587175
DONNAI-BARROW SYNDROME	0.007165523	0.24557123273587175
DESBUQUOIS DYSPLASIA 1	0.0071048199999999995	0.2434908667192159
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.24134651633023757
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.24134651633023757
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.24134651633023757
AMISH LETHAL MICROCEPHALY	0.00704225	0.24134651633023757
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.24134651633023757
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.24134651633023757
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.24134651633023757
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.24134651633023757
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.24134651633023757
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.24134651633023757
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.24134651633023757
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.24134651633023757
OLIVER SYNDROME	0.00704225	0.24134651633023757
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.24134651633023757
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.24134651633023757
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.24134651633023757
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.24134651633023757
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.24134651633023757
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.24134651633023757
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.24134651633023757
17P11.2 MICRODUPLICATION SYNDROME	0.007023504	0.2407040679941054
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.007019369	0.24056235648925603
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.007019369	0.24056235648925603
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.007019369	0.24056235648925603
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.007013809	0.240371808492409
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.007013809	0.240371808492409
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00701338	0.24035710613797595
NEUROFACIODIGITORENAL SYNDROME	0.00701338	0.24035710613797595
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00701338	0.24035710613797595
BARDET-BIEDL SYNDROME	0.00701338	0.24035710613797595
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00701338	0.24035710613797595
SECKEL SYNDROME 5; SCKL5	0.00701338	0.24035710613797595
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00701338	0.24035710613797595
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00701338	0.24035710613797595
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00701338	0.24035710613797595
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00701338	0.24035710613797595
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.006976199999999999	0.23908290208711747
LOEYS-DIETZ SYNDROME 3; LDS3	0.006976199999999999	0.23908290208711747
ACHONDROGENESIS TYPE 1B	0.006976199999999999	0.23908290208711747
ISOLATED CLEFT LIP	0.006976199999999999	0.23908290208711747
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.006905843	0.23667168168888586
RUBINSTEIN-TAYBI SYNDROME	0.006905843	0.23667168168888586
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.006888193000000001	0.2360667946125639
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.006888193000000001	0.2360667946125639
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.006868233999999999	0.2353827752835944
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006868233999999999	0.2353827752835944
PETERS PLUS SYNDROME	0.006868233999999999	0.2353827752835944
ADNP SYNDROME	0.006864098999999999	0.235241063778745
ADAMS-OLIVER SYNDROME 5; AOS5	0.0068640989999999985	0.23524106377874496
LOEYS-DIETZ SYNDROME 5	0.00686069	0.23512423318139763
NATIVE AMERICAN MYOPATHY	0.00686069	0.23512423318139763
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00686069	0.23512423318139763
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.006783694	0.23248548613729056
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.006779558999999999	0.23234377463244113
PALLISTER-KILLIAN SYNDROME	0.006779558999999999	0.23234377463244113
COFFIN-SIRIS SYNDROME 6; CSS6	0.006752723999999999	0.23142410637787453
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.006748589	0.23128239487302518
JOUBERT SYNDROME 24	0.0066965340000000005	0.2294984063881559
NOONAN SYNDROME 6; NS6	0.006668184	0.2285268172315707
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.006668184	0.2285268172315707
15Q OVERGROWTH SYNDROME	0.006664049	0.2283851057267213
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00663754	0.22747660989067484
LATERAL MENINGOCELE SYNDROME	0.006624104	0.22701614174577608
XP22.13P22.2 DUPLICATION SYNDROME	0.006619969	0.22687443024092674
BRANCHIOSKELETOGENITAL SYNDROME	0.006619969	0.22687443024092674
CAREY-FINEMAN-ZITER SYNDROME	0.00655693	0.22471400664861718
PYRUVATE DEHYDROGENASE DEFICIENCY	0.006499893	0.22275927893347958
FREEMAN-SHELDON SYNDROME	0.00647239	0.22181671750231333
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00647239	0.22181671750231333
COG1-CDG	0.00647239	0.22181671750231333
BASAL CELL NEVUS SYNDROME	0.006366759999999999	0.21819664827444396
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.006366759999999999	0.21819664827444396
3C SYNDROME	0.006364424	0.21811659069879025
ELSAHY-WATERS SYNDROME; ESWS	0.006364424	0.21811659069879025
AYME-GRIPP SYNDROME; AYGRP	0.006360289	0.21797487919394087
POTOCKI-SHAFFER SYNDROME	0.006360289	0.21797487919394087
OROFACIODIGITAL SYNDROME I; OFD1	0.006360289	0.21797487919394087
OROFACIODIGITAL SYNDROME TYPE 1	0.006360289	0.21797487919394087
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.006342639000000001	0.2173699921176189
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.006295303	0.21574772953151244
MEND SYNDROME; MEND	0.0062953029999999995	0.2157477295315124
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0062953029999999995	0.2157477295315124
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0062953029999999995	0.2157477295315124
CK SYNDROME	0.0062953029999999995	0.2157477295315124
MEND SYNDROME	0.0062953029999999995	0.2157477295315124
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0062953029999999995	0.2157477295315124
DISTAL 16P11.2 MICRODELETION SYNDROME	0.0062953029999999995	0.2157477295315124
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0062953029999999995	0.2157477295315124
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.0062953029999999995	0.2157477295315124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0062953029999999995	0.2157477295315124
POTOCKI-SHAFFER SYNDROME	0.0062953029999999995	0.2157477295315124
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.0062953029999999995	0.2157477295315124
15Q14 MICRODELETION SYNDROME	0.0062953029999999995	0.2157477295315124
PMM2-CDG	0.0062953029999999995	0.2157477295315124
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00623814	0.21378868364234554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00623814	0.21378868364234554
9P13 MICRODELETION SYNDROME	0.00623814	0.21378868364234554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00623814	0.21378868364234554
FRASER SYNDROME	0.00623814	0.21378868364234554
OMODYSPLASIA 1; OMOD1	0.00623814	0.21378868364234554
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00623814	0.21378868364234554
CLASSICAL EHLERS-DANLOS SYNDROME	0.00623814	0.21378868364234554
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00623814	0.21378868364234554
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00615098	0.21080160389321093
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00615098	0.21080160389321093
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00615098	0.21080160389321093
MIRAGE SYNDROME; MIRAGE	0.006142613	0.21051485657493405
NEONATAL MARFAN SYNDROME	0.0061226299999999996	0.2098300147366257
ARTERIAL TORTUOSITY SYNDROME	0.006078549999999999	0.20831933925083113
SCARF SYNDROME	0.006078549999999999	0.20831933925083113
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.006078549999999999	0.20831933925083113
SHPRINTZEN-GOLDBERG SYNDROME	0.006078549999999999	0.20831933925083113
CHARGE SYNDROME	0.006078549999999999	0.20831933925083113
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.005954339	0.20406247643853462
ADAMS-OLIVER SYNDROME 1; AOS1	0.005838853	0.20010463004215365
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.005838853	0.20010463004215365
CRANIOFRONTONASAL DYSPLASIA	0.005818869999999999	0.19941978820384523
ROBERTS SYNDROME; RBS	0.005818869999999999	0.19941978820384523
GENITOPALATOCARDIAC SYNDROME	0.005818869999999999	0.19941978820384523
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.005818869999999999	0.19941978820384523
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.005818869999999999	0.19941978820384523
MAST SYNDROME	0.00580122	0.19881490112752329
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00580122	0.19881490112752329
DYSTONIA 16; DYT16	0.00580122	0.19881490112752329
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00580122	0.19881490112752329
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00580122	0.19881490112752329
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00580122	0.19881490112752329
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00580122	0.19881490112752329
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00580122	0.19881490112752329
BEHR SYNDROME	0.00580122	0.19881490112752329
TETRASOMY 18P	0.005794749	0.19859313204702014
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.005794749	0.19859313204702014
ISOLATED GLYCEROL KINASE DEFICIENCY	0.005759873	0.19739788889269685
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.005759873	0.19739788889269685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005759873	0.19739788889269685
TAY-SACHS DISEASE	0.005759873	0.19739788889269685
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.005759873	0.19739788889269685
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.005759873	0.19739788889269685
VICI SYNDROME	0.005759873	0.19739788889269685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.005759873	0.19739788889269685
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005759873	0.19739788889269685
SEVERE CANAVAN DISEASE	0.005759873	0.19739788889269685
HARTNUP DISEASE	0.005759873	0.19739788889269685
SCHIZENCEPHALY	0.005759873	0.19739788889269685
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.005759873	0.19739788889269685
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.005759873	0.19739788889269685
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.005759873	0.19739788889269685
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.005759873	0.19739788889269685
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.005759873	0.19739788889269685
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.005759873	0.19739788889269685
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005759873	0.19739788889269685
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.005759873	0.19739788889269685
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.005759873	0.19739788889269685
CENTRAL BILATERAL MACROGYRIA	0.005759873	0.19739788889269685
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.005759873	0.19739788889269685
GALLOWAY-MOWAT SYNDROME	0.005759873	0.19739788889269685
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005759873	0.19739788889269685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.005759873	0.19739788889269685
CANAVAN DISEASE	0.005759873	0.19739788889269685
1Q21.1 MICRODELETION SYNDROME	0.0057543130000000005	0.19720734089584982
TETRASOMY 5P	0.0057543130000000005	0.19720734089584982
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0057543130000000005	0.19720734089584982
TARP SYNDROME	0.0057543130000000005	0.19720734089584982
HADZISELIMOVIC SYNDROME	0.005753884	0.19719263854141683
DISTAL TRISOMY 6P	0.005753884	0.19719263854141683
ALAZAMI-YUAN SYNDROME	0.005753884	0.19719263854141683
SAY-BARBER-MILLER SYNDROME	0.005753884	0.19719263854141683
12Q14 MICRODELETION SYNDROME	0.005753884	0.19719263854141683
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.005753884	0.19719263854141683
OCULOFACIOCARDIODENTAL SYNDROME	0.005753884	0.19719263854141683
DISTAL TRISOMY 18Q	0.005753884	0.19719263854141683
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.005753884	0.19719263854141683
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.005753884	0.19719263854141683
FRONTOOCULAR SYNDROME	0.005753884	0.19719263854141683
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005753884	0.19719263854141683
FORSYTHE-WAKELING SYNDROME; FWS	0.005753884	0.19719263854141683
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005749749	0.19705092703656743
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005601194	0.19195976558483846
SAUL-WILSON SYNDROME; SWILS	0.005601194	0.19195976558483846
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.005597059	0.19181805407998906
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00549746	0.18840467459474283
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00549746	0.18840467459474283
LERI PLEONOSTEOSIS	0.00549746	0.18840467459474283
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00541292	0.18550738544843898
IMMUNODEFICIENCY 49; IMD49	0.005360472999999999	0.18370996264436754
DISTAL MONOSOMY 19P13.3	0.005360472999999999	0.18370996264436754
DIGEORGE SYNDROME; DGS	0.005360472999999999	0.18370996264436754
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005360472999999999	0.18370996264436754
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.005360472999999999	0.18370996264436754
SIALIDOSIS TYPE 2	0.005360472999999999	0.18370996264436754
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005360472999999999	0.18370996264436754
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0052533300000000005	0.18003804105692456
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.005244963	0.17975129373864768
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.005244963	0.17975129373864768
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.1788427979026012
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.17870108639775187
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.005214319	0.17870108639775187
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.005214319	0.17870108639775187
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.17870108639775187
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.17870108639775187
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.17870108639775187
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.17870108639775187
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.17870108639775187
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.17870108639775187
COCKAYNE SYNDROME	0.005214319	0.17870108639775187
RETT SYNDROME	0.005214319	0.17870108639775187
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.17870108639775187
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.17870108639775187
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.17870108639775187
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.17870108639775187
XERODERMA PIGMENTOSUM	0.005214319	0.17870108639775187
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.17870108639775187
DERMOTRICHIC SYNDROME	0.005214319	0.17870108639775187
AUTISM	0.005214319	0.17870108639775187
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.005214319	0.17870108639775187
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.005214319	0.17870108639775187
RETT SYNDROME; RTT	0.005214319	0.17870108639775187
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.17870108639775187
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.17870108639775187
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.005214319	0.17870108639775187
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.17870108639775187
MILLER-DIEKER SYNDROME	0.005214319	0.17870108639775187
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.17870108639775187
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.17870108639775187
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.005214319	0.17870108639775187
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.17870108639775187
EPILEPSY, READING	0.005214319	0.17870108639775187
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.005214319	0.17870108639775187
KRABBE DISEASE	0.005214319	0.17870108639775187
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.17870108639775187
PRIMARY CUTIS VERTICIS GYRATA	0.005214319	0.17870108639775187
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.17870108639775187
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.005214319	0.17870108639775187
LINEAR NEVUS SEBACEUS SYNDROME	0.005214319	0.17870108639775187
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.17870108639775187
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.005214319	0.17870108639775187
BANGSTAD SYNDROME	0.005214319	0.17870108639775187
CEREBROTENDINOUS XANTHOMATOSIS	0.005214319	0.17870108639775187
KABUKI SYNDROME	0.005214319	0.17870108639775187
HUNTINGTON DISEASE-LIKE 1	0.005214319	0.17870108639775187
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.005214319	0.17870108639775187
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.005214319	0.17870108639775187
CEREBROFACIOARTICULAR SYNDROME	0.005212894	0.17865224990575415
TARP SYNDROME; TARPS	0.005212894	0.17865224990575415
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.005212894	0.17865224990575415
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.005208759	0.1785105384009048
NANCE-HORAN SYNDROME	0.00520833	0.17849583604647182
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.00520833	0.17849583604647182
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00520833	0.17849583604647182
FRYNS-SMEETS-THIRY SYNDROME	0.00520833	0.17849583604647182
WARBURG MICRO SYNDROME 2; WARBM2	0.00520833	0.17849583604647182
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00520833	0.17849583604647182
CEREBROOCULONASAL SYNDROME	0.00520833	0.17849583604647182
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00520833	0.17849583604647182
FRAXE INTELLECTUAL DISABILITY	0.00520833	0.17849583604647182
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00520833	0.17849583604647182
%608572 BURN-MCKEOWN SYNDROME	0.00520833	0.17849583604647182
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00520833	0.17849583604647182
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00520833	0.17849583604647182
WOODHOUSE-SAKATI SYNDROME	0.00520833	0.17849583604647182
MENTAL RETARDATION, X-LINKED 45	0.00520833	0.17849583604647182
NIJMEGEN BREAKAGE SYNDROME	0.00520833	0.17849583604647182
BALLER-GEROLD SYNDROME	0.00520833	0.17849583604647182
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00520833	0.17849583604647182
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00520833	0.17849583604647182
RUIJS-AALFS SYNDROME; RJALS	0.00520833	0.17849583604647182
MATERNAL PHENYLKETONURIA	0.005100793	0.17481041159738173
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.005100793	0.17481041159738173
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00505564	0.17326296308989345
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00505564	0.17326296308989345
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00505564	0.17326296308989345
CENTRAL CORE DISEASE	0.00505564	0.17326296308989345
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00505564	0.17326296308989345
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00505564	0.17326296308989345
EHLERS-DANLOS SYNDROME, TYPE VI	0.00505564	0.17326296308989345
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00505564	0.17326296308989345
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00505564	0.17326296308989345
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00505564	0.17326296308989345
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00505564	0.17326296308989345
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.005053304	0.17318290551423973
WEAVER SYNDROME	0.005053304	0.17318290551423973
DISTAL MONOSOMY 6P	0.005053304	0.17318290551423973
COSTELLO SYNDROME; CSTLO	0.005053304	0.17318290551423973
20Q13.33 MICRODELETION SYNDROME	0.005049169	0.17304119400939033
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.004943539	0.169421124781521
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004941203	0.16934106720586725
2Q31.1 MICRODELETION SYNDROME	0.004941203	0.16934106720586725
MUENKE SYNDROME	0.004941203	0.16934106720586725
RUVALCABA SYNDROME	0.004941203	0.16934106720586725
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004863134	0.1666655471400665
SPINOCEREBELLAR ATAXIA 47; SCA47	0.004858999	0.16652383563521714
COG5-CDG	0.004858999	0.16652383563521714
WIEDEMANN-STEINER SYNDROME; WDSTS	0.004856663	0.1664437780595634
HELSMOORTEL-VAN DER AA SYNDROME	0.004856663	0.1664437780595634
3Q29 MICRODUPLICATION SYNDROME	0.004856663	0.1664437780595634
ZTTK SYNDROME; ZTTKS	0.004856663	0.1664437780595634
MAN1B1-CDG	0.004856663	0.1664437780595634
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.004856663	0.1664437780595634
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004856663	0.1664437780595634
JACOBSEN SYNDROME	0.004856663	0.1664437780595634
CHROMOSOME 10Q26 DELETION SYNDROME	0.004856663	0.1664437780595634
ICF SYNDROME	0.004819054	0.16515487165427192
PERIPHERAL HYPOTHYROIDISM	0.004819054	0.16515487165427192
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004819054	0.16515487165427192
TOWNES-BROCKS SYNDROME 1; TBS1	0.004819054	0.16515487165427192
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004819054	0.16515487165427192
ABLEPHARON MACROSTOMIA SYNDROME	0.004819054	0.16515487165427192
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004819054	0.16515487165427192
FAMILIAL THYROID DYSHORMONOGENESIS	0.004819054	0.16515487165427192
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004819054	0.16515487165427192
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004819054	0.16515487165427192
THYROID ECTOPIA	0.004819054	0.16515487165427192
FANCONI ANEMIA	0.004819054	0.16515487165427192
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.004819054	0.16515487165427192
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004819054	0.16515487165427192
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.16515487165427192
THYROID HEMIAGENESIS	0.004819054	0.16515487165427192
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004819054	0.16515487165427192
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004819054	0.16515487165427192
CONGENITAL HYPOTHYROIDISM	0.004819054	0.16515487165427192
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.004819054	0.16515487165427192
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004814918999999999	0.16501316014942252
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.16501316014942252
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004814918999999999	0.16501316014942252
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.004814918999999999	0.16501316014942252
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.004814918999999999	0.16501316014942252
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.16501316014942252
DISTAL MONOSOMY 3P	0.004814918999999999	0.16501316014942252
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00475188	0.16285273655711302
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00475188	0.16285273655711302
ATELOSTEOGENESIS TYPE I	0.00475188	0.16285273655711302
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00475188	0.16285273655711302
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00475188	0.16285273655711302
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00475188	0.16285273655711302
ATELOSTEOGENESIS, TYPE I; AO1	0.00475188	0.16285273655711302
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00475188	0.16285273655711302
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00475188	0.16285273655711302
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00475188	0.16285273655711302
MULTIPLE SYNOSTOSES SYNDROME 2	0.00475188	0.16285273655711302
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00475188	0.16285273655711302
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00475188	0.16285273655711302
LETHAL KNIEST-LIKE DYSPLASIA	0.00475188	0.16285273655711302
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.004703544	0.16119620274855206
CONGENITAL HYDROCEPHALUS	0.004699409	0.1610544912437027
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.004699409	0.1610544912437027
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004699409	0.1610544912437027
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.004699409	0.1610544912437027
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004699409	0.1610544912437027
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.1601459954076562
SACCHAROPINURIA	0.0046729	0.1601459954076562
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0046729	0.1601459954076562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.1601459954076562
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.1601459954076562
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.1601459954076562
ARGININOSUCCINIC ACIDURIA	0.0046729	0.1601459954076562
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.1601459954076562
SCHIZOPHRENIA	0.0046729	0.1601459954076562
BONNEMANN-MEINECKE-REICH SYNDROME	0.0046729	0.1601459954076562
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.1601459954076562
ISAAC SYNDROME	0.0046729	0.1601459954076562
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.1601459954076562
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.1601459954076562
TEEBI-SHALTOUT SYNDROME; TBSH	0.00466734	0.15995544741080917
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00466734	0.15995544741080917
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00466734	0.15995544741080917
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00466734	0.15995544741080917
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00466734	0.15995544741080917
TRISOMY 8Q	0.004559374	0.15625532060728609
FLOATING-HARBOR SYNDROME	0.004559374	0.15625532060728609
HALL-RIGGS SYNDROME	0.004555239	0.1561136091024367
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555239	0.1561136091024367
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.004535253	0.155428664450461
16P13.2 MICRODELETION SYNDROME	0.004535253	0.155428664450461
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004535253	0.155428664450461
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.004535253	0.155428664450461
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.004535253	0.155428664450461
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004535253	0.155428664450461
FOIX-CHAVANY-MARIE SYNDROME	0.004535253	0.155428664450461
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004535253	0.155428664450461
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004535253	0.155428664450461
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.004535253	0.155428664450461
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004535253	0.155428664450461
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.004535253	0.155428664450461
L1 SYNDROME	0.004535253	0.155428664450461
FREE SIALIC ACID STORAGE DISEASE	0.004535253	0.155428664450461
NIEMANN-PICK DISEASE TYPE C	0.004535253	0.155428664450461
MARTSOLF SYNDROME	0.00450775	0.15448610301929472
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00450775	0.15448610301929472
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00450775	0.15448610301929472
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00440212	0.15086603379142535
CHST3-RELATED SKELETAL DYSPLASIA	0.00440212	0.15086603379142535
LARON SYNDROME	0.00440212	0.15086603379142535
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00440212	0.15086603379142535
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00440212	0.15086603379142535
ODONTOCHONDRODYSPLASIA; ODCD	0.00440212	0.15086603379142535
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00440212	0.15086603379142535
TRISOMY 9P	0.0043997839999999995	0.15078597621577164
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.0043997839999999995	0.15078597621577164
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0043997839999999995	0.15078597621577164
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0043997839999999995	0.15078597621577164
ROIFMAN SYNDROME; RFMN	0.0043997839999999995	0.15078597621577164
OCCIPITAL HORN SYNDROME	0.0043997839999999995	0.15078597621577164
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004395649	0.15064426471092227
THANATOPHORIC DYSPLASIA	0.004395649	0.15064426471092227
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.004395649	0.15064426471092227
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00431758	0.14796874464512152
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00431758	0.14796874464512152
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00431758	0.14796874464512152
OGDEN SYNDROME; OGDNS	0.004315244	0.1478886870694678
OPITZ G/BBB SYNDROME	0.004315244	0.1478886870694678
HEREDITARY OROTIC ACIDURIA	0.004315244	0.1478886870694678
TREACHER-COLLINS SYNDROME	0.004315244	0.1478886870694678
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.004315244	0.1478886870694678
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.004315244	0.1478886870694678
JOUBERT SYNDROME 10	0.004315244	0.1478886870694678
17Q24.2 MICRODELETION SYNDROME	0.0043111090000000005	0.1477469755646184
RING CHROMOSOME 10 SYNDROME	0.0043111090000000005	0.1477469755646184
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0043111090000000005	0.1477469755646184
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0043111090000000005	0.1477469755646184
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0042734999999999995	0.14645806915932694
COOPER-JABS SYNDROME	0.0042734999999999995	0.14645806915932694
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.0042734999999999995	0.14645806915932694
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.14645806915932694
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0042734999999999995	0.14645806915932694
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0042734999999999995	0.14645806915932694
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.0042734999999999995	0.14645806915932694
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0042734999999999995	0.14645806915932694
EHLERS-DANLOS SYNDROME, TYPE I	0.0042734999999999995	0.14645806915932694
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.14645806915932694
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.14645806915932694
FLOATING-HARBOR SYNDROME	0.0042734999999999995	0.14645806915932694
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0042734999999999995	0.14645806915932694
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.14645806915932694
HUNTER-MACDONALD SYNDROME	0.0042734999999999995	0.14645806915932694
BLADDER EXSTROPHY	0.0042734999999999995	0.14645806915932694
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.14645806915932694
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.14645806915932694
GAPO SYNDROME	0.0042734999999999995	0.14645806915932694
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.0042734999999999995	0.14645806915932694
FOCAL DERMAL HYPOPLASIA	0.0042734999999999995	0.14645806915932694
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.14645806915932694
PROGEROID SYNDROME, PETTY TYPE	0.0042734999999999995	0.14645806915932694
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0042734999999999995	0.14645806915932694
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0042734999999999995	0.14645806915932694
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0042734999999999995	0.14645806915932694
ACHONDROGENESIS	0.0042734999999999995	0.14645806915932694
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.14645806915932694
X-LINKED EHLERS-DANLOS SYNDROME	0.0042734999999999995	0.14645806915932694
HURLER-SCHEIE SYNDROME	0.0042734999999999995	0.14645806915932694
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.14645806915932694
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.14645806915932694
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0042734999999999995	0.14645806915932694
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0042734999999999995	0.14645806915932694
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0042734999999999995	0.14645806915932694
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.14645806915932694
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0042734999999999995	0.14645806915932694
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.14645806915932694
LEPRECHAUNISM	0.0042734999999999995	0.14645806915932694
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0042734999999999995	0.14645806915932694
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.14645806915932694
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00415799	0.14249940025360708
3Q27.3 MICRODELETION SYNDROME	0.00415799	0.14249940025360708
SOTOS SYNDROME 2	0.00415799	0.14249940025360708
JUVENILE POLYPOSIS OF INFANCY	0.00415799	0.14249940025360708
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00415799	0.14249940025360708
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.13755851811234107
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.13755851811234107
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0040138199999999995	0.13755851811234107
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.13755851811234107
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.13755851811234107
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0040138199999999995	0.13755851811234107
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.13755851811234107
CHARLIE M SYNDROME	0.0040138199999999995	0.13755851811234107
CRANIOECTODERMAL DYSPLASIA 1	0.0040138199999999995	0.13755851811234107
GORLIN SYNDROME	0.0040138199999999995	0.13755851811234107
FRONTONASAL DYSPLASIA 1; FND1	0.0040138199999999995	0.13755851811234107
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.0040138199999999995	0.13755851811234107
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.13755851811234107
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0040138199999999995	0.13755851811234107
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.13755851811234107
SHORT SYNDROME	0.0040138199999999995	0.13755851811234107
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0040138199999999995	0.13755851811234107
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.13755851811234107
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0040138199999999995	0.13755851811234107
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0040138199999999995	0.13755851811234107
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.13755851811234107
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0040138199999999995	0.13755851811234107
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.13687357346036536
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.13687357346036536
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.003993834	0.13687357346036536
FRIED SYNDROME	0.003993834	0.13687357346036536
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.13687357346036536
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.13687357346036536
RIDDLE SYNDROME	0.003993834	0.13687357346036536
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.13687357346036536
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.13687357346036536
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.13687357346036536
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003993834	0.13687357346036536
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.13687357346036536
HYPERMANGANESEMIA WITH DYSTONIA 2	0.003993834	0.13687357346036536
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.13687357346036536
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.13687357346036536
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.13673186195551598
LYNCH SYNDROME	0.003989699	0.13673186195551598
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.13673186195551598
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003989699	0.13673186195551598
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.003989699	0.13673186195551598
CHOREOACANTHOCYTOSIS	0.003989699	0.13673186195551598
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003989699	0.13673186195551598
SUBEPENDYMOMA	0.003989699	0.13673186195551598
EPENDYMOMA	0.003989699	0.13673186195551598
KALLMANN SYNDROME	0.003989699	0.13673186195551598
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.003989699	0.13673186195551598
ALZHEIMER DISEASE 3; AD	0.003989699	0.13673186195551598
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.13673186195551598
X-LINKED CENTRONUCLEAR MYOPATHY	0.003989699	0.13673186195551598
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.13673186195551598
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.13673186195551598
TENORIO SYNDROME; TNORS	0.003989699	0.13673186195551598
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.13673186195551598
DYSEQUILIBRIUM SYNDROME	0.003989699	0.13673186195551598
BEHÇET DISEASE	0.003989699	0.13673186195551598
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003989699	0.13673186195551598
FAMILIAL COLORECTAL CANCER TYPE X	0.003989699	0.13673186195551598
KUFOR-RAKEB SYNDROME	0.003989699	0.13673186195551598
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.003989699	0.13673186195551598
ATAXIA-TELANGIECTASIA	0.003989699	0.13673186195551598
CENTRONUCLEAR MYOPATHY	0.003989699	0.13673186195551598
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.13673186195551598
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003989699	0.13673186195551598
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00385423	0.13208917372082665
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00385423	0.13208917372082665
FIBROCHONDROGENESIS	0.00385423	0.13208917372082665
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00385423	0.13208917372082665
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00385423	0.13208917372082665
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00385423	0.13208917372082665
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0037896729999999995	0.12987672641283116
48,XXXY SYNDROME	0.0037896729999999995	0.12987672641283116
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.0037896729999999995	0.12987672641283116
8P11.2 DELETION SYNDROME	0.0037896729999999995	0.12987672641283116
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0037896729999999995	0.12987672641283116
ACROMELIC FRONTONASAL DYSPLASIA	0.0037896729999999995	0.12987672641283116
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0037896729999999995	0.12987672641283116
DISTAL MONOSOMY 15Q	0.0037896729999999995	0.12987672641283116
49,XXXXY SYNDROME	0.0037896729999999995	0.12987672641283116
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0037896729999999995	0.12987672641283116
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0037896729999999995	0.12987672641283116
1Q21.1 MICRODUPLICATION SYNDROME	0.0037896729999999995	0.12987672641283116
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0037896729999999995	0.12987672641283116
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0037896729999999995	0.12987672641283116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0037896729999999995	0.12987672641283116
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0037896729999999995	0.12987672641283116
JABERI-ELAHI SYNDROME; JABELS	0.0037896729999999995	0.12987672641283116
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00376969	0.1291918845745228
HYPERTELORISM, TEEBI TYPE; TBHS	0.00376969	0.1291918845745228
FRONTOMETAPHYSEAL DYSPLASIA	0.00376969	0.1291918845745228
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00376969	0.1291918845745228
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00376969	0.1291918845745228
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00376969	0.1291918845745228
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00376969	0.1291918845745228
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00376969	0.1291918845745228
RING CHROMOSOME 1 SYNDROME	0.00376969	0.1291918845745228
DISTAL MONOSOMY 10P	0.00376969	0.1291918845745228
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00376969	0.1291918845745228
OTOPALATODIGITAL SYNDROME TYPE 1	0.00376969	0.1291918845745228
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00376969	0.1291918845745228
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00376969	0.1291918845745228
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00376969	0.1291918845745228
MONOSOMY 5P	0.00376969	0.1291918845745228
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00376969	0.1291918845745228
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00376969	0.1291918845745228
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00376969	0.1291918845745228
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00376969	0.1291918845745228
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00376969	0.1291918845745228
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00376969	0.1291918845745228
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.11817677096542037
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.11817677096542037
KENNEDY DISEASE	0.00344828	0.11817677096542037
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.11817677096542037
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.11817677096542037
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.11817677096542037
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.11817677096542037
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.11817677096542037
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.11817677096542037
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.11817677096542037
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.11817677096542037
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00344828	0.11817677096542037
SPONASTRIME DYSPLASIA	0.00344828	0.11817677096542037
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.11817677096542037
MYOTONIA PERMANENS	0.00344828	0.11817677096542037
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.11817677096542037
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.11817677096542037
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.11817677096542037
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.11817677096542037
NONAKA MYOPATHY	0.00344828	0.11817677096542037
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.11817677096542037
MYOTONIA FLUCTUANS	0.00344828	0.11817677096542037
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.11817677096542037
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.11817677096542037
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.11817677096542037
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.11817677096542037
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.11817677096542037
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.11817677096542037
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.11817677096542037
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.11817677096542037
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.11817677096542037
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.11817677096542037
POLYMYOSITIS	0.00344828	0.11817677096542037
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.11817677096542037
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.11817677096542037
ROUSSY-LÉVY SYNDROME	0.00344828	0.11817677096542037
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.11817677096542037
MASA SYNDROME	0.00344828	0.11817677096542037
BRITTLE CORNEA SYNDROME	0.00344828	0.11817677096542037
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.11817677096542037
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.11817677096542037
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.11817677096542037
DYSTONIA 23; DYT23	0.00344828	0.11817677096542037
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.11817677096542037
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.11817677096542037
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.11817677096542037
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.11817677096542037
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.11817677096542037
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.11817677096542037
OSTEOCHONDRITIS DISSECANS	0.00344828	0.11817677096542037
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.11817677096542037
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.11817677096542037
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.11817677096542037
CLASSIC GALACTOSEMIA	0.00344828	0.11817677096542037
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.11817677096542037
BENIGN HEREDITARY CHOREA	0.00344828	0.11817677096542037
RICHARDS-RUNDLE SYNDROME	0.00344828	0.11817677096542037
ATAXIA WITH VITAMIN E DEFICIENCY	0.00344828	0.11817677096542037
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.11817677096542037
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.11817677096542037
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.11817677096542037
MANGANESE POISONING	0.00344828	0.11817677096542037
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.11817677096542037
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.11817677096542037
VON HIPPEL-LINDAU DISEASE	0.00344828	0.11817677096542037
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.11817677096542037
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.11817677096542037
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.11817677096542037
CYSTINOSIS	0.00344828	0.11817677096542037
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.11817677096542037
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.11817677096542037
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.11817677096542037
THORACOMELIC DYSPLASIA	0.00344828	0.11817677096542037
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.11817677096542037
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.11817677096542037
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.11817677096542037
TRISOMY XQ28	0.00344828	0.11817677096542037
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00344828	0.11817677096542037
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.11817677096542037
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.11817677096542037
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.11817677096542037
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00344828	0.11817677096542037
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00344828	0.11817677096542037
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.11817677096542037
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.11817677096542037
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.11817677096542037
KUSKOKWIM SYNDROME	0.00344828	0.11817677096542037
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.11817677096542037
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.11817677096542037
NEMALINE MYOPATHY 6	0.00344828	0.11817677096542037
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.11817677096542037
PSEUDOACHONDROPLASIA	0.00344828	0.11817677096542037
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.11817677096542037
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.11817677096542037
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.11817677096542037
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.11817677096542037
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.11817677096542037
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.11817677096542037
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.11817677096542037
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.11817677096542037
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.11817677096542037
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.11817677096542037
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.11817677096542037
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.11817677096542037
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.11817677096542037
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.11817677096542037
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.11817677096542037
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.11817677096542037
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.11817677096542037
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.11817677096542037
VICI SYNDROME; VICIS	0.003439913	0.11789002364714352
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.003439913	0.11789002364714352
SPINOCEREBELLAR ATAXIA TYPE 13	0.003439913	0.11789002364714352
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.003439913	0.11789002364714352
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.003439913	0.11789002364714352
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.003439913	0.11789002364714352
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.003439913	0.11789002364714352
CODAS SYNDROME	0.003439913	0.11789002364714352
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003439913	0.11789002364714352
PRADER-WILLI SYNDROME; PWS	0.003439913	0.11789002364714352
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.003439913	0.11789002364714352
KETOADIPICACIDURIA	0.003439913	0.11789002364714352
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.003439913	0.11789002364714352
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003439913	0.11789002364714352
ATELOSTEOGENESIS TYPE III	0.003248254	0.11132163542273556
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.003248254	0.11132163542273556
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.003248254	0.11132163542273556
LARSEN-LIKE SYNDROME	0.003248254	0.11132163542273556
DIAPHANOSPONDYLODYSOSTOSIS	0.003248254	0.11132163542273556
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.003248254	0.11132163542273556
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003248254	0.11132163542273556
ROTHMUND-THOMSON SYNDROME	0.003248254	0.11132163542273556
RAHMAN SYNDROME	0.003248254	0.11132163542273556
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.003248254	0.11132163542273556
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.003248254	0.11132163542273556
RICHARDS-RUNDLE SYNDROME; RRNS	0.003248254	0.11132163542273556
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.003248254	0.11132163542273556
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003248254	0.11132163542273556
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.003248254	0.11132163542273556
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.003248254	0.11132163542273556
SECKEL SYNDROME 9; SCKL9	0.003248254	0.11132163542273556
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.003248254	0.11132163542273556
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.003248254	0.11132163542273556
MOSAIC TRISOMY 9	0.003248254	0.11132163542273556
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.003248254	0.11132163542273556
ISOLATED SPINA BIFIDA	0.0032441189999999997	0.11117992391788616
MARDEN-WALKER SYNDROME	0.0032441189999999997	0.11117992391788616
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.0032441189999999997	0.11117992391788616
CYSTATHIONINURIA	0.0032441189999999997	0.11117992391788616
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0032441189999999997	0.11117992391788616
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.0032441189999999997	0.11117992391788616
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0032441189999999997	0.11117992391788616
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0032441189999999997	0.11117992391788616
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0032441189999999997	0.11117992391788616
GRACILE BONE DYSPLASIA; GCLEB	0.003136153	0.10747979711436309
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.003136153	0.10747979711436309
HOLOPROSENCEPHALY	0.003136153	0.10747979711436309
COWDEN SYNDROME	0.003136153	0.10747979711436309
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.003136153	0.10747979711436309
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.003136153	0.10747979711436309
C SYNDROME	0.003051613	0.10458250796805925
BARAITSER-WINTER SYNDROME 1; BRWS1	0.003051613	0.10458250796805925
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003051613	0.10458250796805925
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.003051613	0.10458250796805925
8Q24.3 MICRODELETION SYNDROME	0.003051613	0.10458250796805925
SIALURIA	0.003051613	0.10458250796805925
BOHRING-OPITZ SYNDROME	0.003051613	0.10458250796805925
COFFIN-SIRIS SYNDROME	0.003051613	0.10458250796805925
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.003051613	0.10458250796805925
MICRO SYNDROME	0.003051613	0.10458250796805925
KABUKI SYNDROME 1	0.003051613	0.10458250796805925
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.003051613	0.10458250796805925
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003051613	0.10458250796805925
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.003051613	0.10458250796805925
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.003051613	0.10458250796805925
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.003051613	0.10458250796805925
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003051613	0.10458250796805925
BOHRING-OPITZ SYNDROME	0.003051613	0.10458250796805925
OCULOECTODERMAL SYNDROME; OES	0.003051613	0.10458250796805925
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.003051613	0.10458250796805925
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.003051613	0.10458250796805925
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003051613	0.10458250796805925
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.003051613	0.10458250796805925
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.003051613	0.10458250796805925
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.003051613	0.10458250796805925
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.003051613	0.10458250796805925
CHROMOSOME 1P35 DELETION SYNDROME	0.003051613	0.10458250796805925
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0028984939999999997	0.09933493265704789
DYSTONIA 28, CHILDHOOD-ONSET	0.0028984939999999997	0.09933493265704789
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0028984939999999997	0.09933493265704789
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0028984939999999997	0.09933493265704789
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0028984939999999997	0.09933493265704789
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0028984939999999997	0.09933493265704789
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.0028984939999999997	0.09933493265704789
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.0028984939999999997	0.09933493265704789
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0028984939999999997	0.09933493265704789
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0028984939999999997	0.09933493265704789
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.0028984939999999997	0.09933493265704789
BRAIN-LUNG-THYROID SYNDROME	0.0028984939999999997	0.09933493265704789
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0028984939999999997	0.09933493265704789
SPINOCEREBELLAR ATAXIA TYPE 7	0.0028984939999999997	0.09933493265704789
DUCHENNE MUSCULAR DYSTROPHY	0.0028984939999999997	0.09933493265704789
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0028984939999999997	0.09933493265704789
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0028984939999999997	0.09933493265704789
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0028984939999999997	0.09933493265704789
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0028984939999999997	0.09933493265704789
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002894359	0.09919322115219852
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.002894359	0.09919322115219852
47,XYY SYNDROME	0.002894359	0.09919322115219852
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.002894359	0.09919322115219852
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002894359	0.09919322115219852
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.002894359	0.09919322115219852
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002894359	0.09919322115219852
EPISODIC ATAXIA, TYPE 6	0.002894359	0.09919322115219852
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002894359	0.09919322115219852
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002894359	0.09919322115219852
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.002894359	0.09919322115219852
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.002894359	0.09919322115219852
PRADER-WILLI SYNDROME	0.002894359	0.09919322115219852
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002894359	0.09919322115219852
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002894359	0.09919322115219852
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002894359	0.09919322115219852
CAMOS SYNDROME	0.002894359	0.09919322115219852
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.002894359	0.09919322115219852
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.002894359	0.09919322115219852
LISSENCEPHALY 3; LIS3	0.002894359	0.09919322115219852
CYCLIC VOMITING SYNDROME	0.002894359	0.09919322115219852
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002894359	0.09919322115219852
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002894359	0.09919322115219852
BETA-KETOTHIOLASE DEFICIENCY	0.002894359	0.09919322115219852
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.002894359	0.09919322115219852
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002894359	0.09919322115219852
MICROPHTHALMIA, SYNDROMIC 1	0.002894359	0.09919322115219852
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.002894359	0.09919322115219852
GABA-TRANSAMINASE DEFICIENCY	0.002892023	0.0991131635765448
15Q11Q13 MICRODUPLICATION SYNDROME	0.002892023	0.0991131635765448
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002892023	0.0991131635765448
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002892023	0.0991131635765448
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.002892023	0.0991131635765448
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002892023	0.0991131635765448
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.002892023	0.0991131635765448
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002892023	0.0991131635765448
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.002892023	0.0991131635765448
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002892023	0.0991131635765448
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002892023	0.0991131635765448
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.002892023	0.0991131635765448
MEVALONIC ACIDURIA	0.002892023	0.0991131635765448
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.002892023	0.0991131635765448
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002892023	0.0991131635765448
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.002892023	0.0991131635765448
611961 STEVENSON-CAREY SYNDROME	0.002892023	0.0991131635765448
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002892023	0.0991131635765448
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.002892023	0.0991131635765448
LUSCAN-LUMISH SYNDROME; LLS	0.002892023	0.0991131635765448
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002892023	0.0991131635765448
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002892023	0.0991131635765448
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.002892023	0.0991131635765448
CHROMOSOME 16P13.3 DELETION SYNDROME	0.002892023	0.0991131635765448
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002892023	0.0991131635765448
19P13.13 MICRODELETION SYNDROME	0.002892023	0.0991131635765448
22Q11.2 MICRODUPLICATION SYNDROME	0.002892023	0.0991131635765448
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.002892023	0.0991131635765448
MONOSOMY 9P	0.002892023	0.0991131635765448
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0027026999999999997	0.09262483292779053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.0027026999999999997	0.09262483292779053
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0027026999999999997	0.09262483292779053
LARYNGEAL ABDUCTOR PARALYSIS	0.0027026999999999997	0.09262483292779053
FIBULAR HEMIMELIA	0.0027026999999999997	0.09262483292779053
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.0027026999999999997	0.09262483292779053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.0027026999999999997	0.09262483292779053
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
PRUNE BELLY SYNDROME	0.0027026999999999997	0.09262483292779053
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0027026999999999997	0.09262483292779053
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027026999999999997	0.09262483292779053
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.0027026999999999997	0.09262483292779053
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.0027026999999999997	0.09262483292779053
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027026999999999997	0.09262483292779053
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0027026999999999997	0.09262483292779053
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.0027026999999999997	0.09262483292779053
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0027026999999999997	0.09262483292779053
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.0027026999999999997	0.09262483292779053
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
TIBIAL HEMIMELIA	0.0027026999999999997	0.09262483292779053
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027026999999999997	0.09262483292779053
CAUDAL REGRESSION SEQUENCE	0.0027026999999999997	0.09262483292779053
CRANE-HEISE SYNDROME	0.0027026999999999997	0.09262483292779053
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0027026999999999997	0.09262483292779053
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0027026999999999997	0.09262483292779053
ELLIS-VAN CREVELD SYNDROME	0.0027026999999999997	0.09262483292779053
MEIER-GORLIN SYNDROME 1; MGORS1	0.0027026999999999997	0.09262483292779053
MECKEL SYNDROME, TYPE 6; MKS6	0.0027026999999999997	0.09262483292779053
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.0027026999999999997	0.09262483292779053
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0027026999999999997	0.09262483292779053
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.09262483292779053
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.0027026999999999997	0.09262483292779053
FEMORAL-FACIAL SYNDROME	0.0027026999999999997	0.09262483292779053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0027026999999999997	0.09262483292779053
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0027026999999999997	0.09262483292779053
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0027026999999999997	0.09262483292779053
ERYTHEMA OF ACRAL REGIONS	0.0027026999999999997	0.09262483292779053
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0027026999999999997	0.09262483292779053
RENAL AGENESIS	0.0027026999999999997	0.09262483292779053
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0027026999999999997	0.09262483292779053
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.0027026999999999997	0.09262483292779053
ATELOSTEOGENESIS, TYPE II	0.0027026999999999997	0.09262483292779053
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.0027026999999999997	0.09262483292779053
STÜVE-WIEDEMANN SYNDROME	0.0027026999999999997	0.09262483292779053
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0027026999999999997	0.09262483292779053
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0027026999999999997	0.09262483292779053
ULBRIGHT-HODES SYNDROME	0.0027026999999999997	0.09262483292779053
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.0027026999999999997	0.09262483292779053
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0027026999999999997	0.09262483292779053
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0027026999999999997	0.09262483292779053
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0027026999999999997	0.09262483292779053
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0027026999999999997	0.09262483292779053
PELVIS-SHOULDER DYSPLASIA	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0027026999999999997	0.09262483292779053
MASA SYNDROME	0.0027026999999999997	0.09262483292779053
NAIL-PATELLA SYNDROME	0.0027026999999999997	0.09262483292779053
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0027026999999999997	0.09262483292779053
INIENCEPHALY	0.0027026999999999997	0.09262483292779053
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0027026999999999997	0.09262483292779053
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0027026999999999997	0.09262483292779053
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0027026999999999997	0.09262483292779053
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0027026999999999997	0.09262483292779053
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.0027026999999999997	0.09262483292779053
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0027026999999999997	0.09262483292779053
BRUCK SYNDROME	0.0027026999999999997	0.09262483292779053
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0027026999999999997	0.09262483292779053
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0027026999999999997	0.09262483292779053
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027026999999999997	0.09262483292779053
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0027026999999999997	0.09262483292779053
KYPHOMELIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0027026999999999997	0.09262483292779053
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0027026999999999997	0.09262483292779053
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0027026999999999997	0.09262483292779053
BRACHYDACTYLY TYPE A4	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0027026999999999997	0.09262483292779053
BRACHYDACTYLY TYPE A1	0.0027026999999999997	0.09262483292779053
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.0027026999999999997	0.09262483292779053
NIEVERGELT SYNDROME	0.0027026999999999997	0.09262483292779053
BRUCK SYNDROME 2	0.0027026999999999997	0.09262483292779053
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027026999999999997	0.09262483292779053
POPLITEAL PTERYGIUM SYNDROME	0.0027026999999999997	0.09262483292779053
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0027026999999999997	0.09262483292779053
MICROTRIPLICATION 11Q24.1	0.0027026999999999997	0.09262483292779053
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.0027026999999999997	0.09262483292779053
CLOACAL EXSTROPHY	0.0027026999999999997	0.09262483292779053
AMYLOIDOSIS	0.0027026999999999997	0.09262483292779053
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027026999999999997	0.09262483292779053
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.0027026999999999997	0.09262483292779053
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0027026999999999997	0.09262483292779053
LAMBERT SYNDROME	0.0027026999999999997	0.09262483292779053
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0027026999999999997	0.09262483292779053
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0027026999999999997	0.09262483292779053
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.08892470612426746
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0025947339999999996	0.08892470612426746
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.08892470612426746
BARDET-BIEDL SYNDROME 1; BBS1	0.0025947339999999996	0.08892470612426746
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.08892470612426746
PHENOBARBITAL EMBRYOPATHY	0.0025947339999999996	0.08892470612426746
TEMTAMY SYNDROME	0.0025947339999999996	0.08892470612426746
BARATELA-SCOTT SYNDROME	0.0025947339999999996	0.08892470612426746
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.08892470612426746
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0025947339999999996	0.08892470612426746
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0025947339999999996	0.08892470612426746
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.08892470612426746
CODAS SYNDROME	0.0025947339999999996	0.08892470612426746
TETRASOMY X	0.0025947339999999996	0.08892470612426746
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.08892470612426746
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.08892470612426746
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.08892470612426746
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.08892470612426746
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.08892470612426746
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.08892470612426746
ROBERTS SYNDROME	0.0025947339999999996	0.08892470612426746
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0025947339999999996	0.08892470612426746
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0025947339999999996	0.08892470612426746
CHARGE SYNDROME	0.0025947339999999996	0.08892470612426746
OROFACIODIGITAL SYNDROME VI	0.0025947339999999996	0.08892470612426746
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0025947339999999996	0.08892470612426746
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0025947339999999996	0.08892470612426746
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.08892470612426746
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.08892470612426746
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.08878299461941809
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002590599	0.08878299461941809
CONO-SPONDYLAR DYSPLASIA	0.002590599	0.08878299461941809
CRANIOSYNOSTOSIS 2	0.002590599	0.08878299461941809
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002590599	0.08878299461941809
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002590599	0.08878299461941809
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.08878299461941809
DUBOWITZ SYNDROME	0.002590599	0.08878299461941809
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002590599	0.08878299461941809
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.08878299461941809
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.002590599	0.08878299461941809
PGM3-CDG	0.002590599	0.08878299461941809
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.08878299461941809
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.002590599	0.08878299461941809
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.08602741697796362
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.08602741697796362
8Q22.1 MICRODELETION SYNDROME	0.0025101940000000003	0.08602741697796362
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0025101940000000003	0.08602741697796362
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.08602741697796362
HURLER SYNDROME	0.0025101940000000003	0.08602741697796362
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0025101940000000003	0.08602741697796362
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.08602741697796362
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.08602741697796362
CHROMOSOME 18P DELETION SYNDROME	0.0025101940000000003	0.08602741697796362
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0025101940000000003	0.08602741697796362
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0025101940000000003	0.08602741697796362
SYNDROMIC DIARRHEA	0.0025101940000000003	0.08602741697796362
PENTASOMY X	0.0025101940000000003	0.08602741697796362
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.08602741697796362
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.08602741697796362
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0025101940000000003	0.08602741697796362
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0025101940000000003	0.08602741697796362
TRISOMY 12P	0.0025101940000000003	0.08602741697796362
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.08602741697796362
8Q12 MICRODUPLICATION SYNDROME	0.0025101940000000003	0.08602741697796362
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0025101940000000003	0.08602741697796362
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.08602741697796362
STEEL SYNDROME; STLS	0.0025101940000000003	0.08602741697796362
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0025101940000000003	0.08602741697796362
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.08602741697796362
MIETENS SYNDROME	0.0025101940000000003	0.08602741697796362
LIG4 SYNDROME	0.0025101940000000003	0.08602741697796362
SWEENEY-COX SYNDROME; SWCOS	0.0025101940000000003	0.08602741697796362
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.002506059	0.08588570547311425
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.002506059	0.08588570547311425
RENPENNING SYNDROME 1; RENS1	0.002506059	0.08588570547311425
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002506059	0.08588570547311425
GLUTAMINE DEFICIENCY, CONGENITAL	0.002506059	0.08588570547311425
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002506059	0.08588570547311425
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002506059	0.08588570547311425
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.002506059	0.08588570547311425
HENNEKAM-BEEMER SYNDROME	0.002506059	0.08588570547311425
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002506059	0.08588570547311425
ZUNICH NEUROECTODERMAL SYNDROME	0.002506059	0.08588570547311425
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.002506059	0.08588570547311425
OHDO SYNDROME	0.002506059	0.08588570547311425
ACROCARDIOFACIAL SYNDROME	0.002506059	0.08588570547311425
COFS SYNDROME	0.002506059	0.08588570547311425
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002506059	0.08588570547311425
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.08588570547311425
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.08588570547311425
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.08588570547311425
FRYNS SYNDROME	0.002506059	0.08588570547311425
FILIPPI SYNDROME; FLPIS	0.002506059	0.08588570547311425
8P INVERTED DUPLICATION/DELETION SYNDROME	0.002506059	0.08588570547311425
INTELLECTUAL DISABILITY, WOLFF TYPE	0.002506059	0.08588570547311425
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00235294	0.08063813016210289
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.00235294	0.08063813016210289
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00235294	0.08063813016210289
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00235294	0.08063813016210289
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00235294	0.08063813016210289
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00235294	0.08063813016210289
INTERMEDIATE NEMALINE MYOPATHY	0.00235294	0.08063813016210289
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.00235294	0.08063813016210289
GLYCOGEN STORAGE DISEASE IXA	0.00235294	0.08063813016210289
GLYCOGEN STORAGE DISEASE IXC	0.00235294	0.08063813016210289
CAP MYOPATHY	0.00235294	0.08063813016210289
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00235294	0.08063813016210289
AMISH NEMALINE MYOPATHY	0.00235294	0.08063813016210289
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00235294	0.08063813016210289
GILLESPIE SYNDROME; GLSP	0.00235294	0.08063813016210289
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00235294	0.08063813016210289
MEIER-GORLIN SYNDROME 5; MGORS5	0.00235294	0.08063813016210289
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00235294	0.08063813016210289
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00235294	0.08063813016210289
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00235294	0.08063813016210289
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00235294	0.08063813016210289
%614990 USHER SYNDROME, TYPE IK; USH1K	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00235294	0.08063813016210289
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00235294	0.08063813016210289
SENGERS SYNDROME	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00235294	0.08063813016210289
TEMPLE SYNDROME	0.00235294	0.08063813016210289
PURE MITOCHONDRIAL MYOPATHY	0.00235294	0.08063813016210289
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00235294	0.08063813016210289
LESCH-NYHAN SYNDROME; LNS	0.00235294	0.08063813016210289
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00235294	0.08063813016210289
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00235294	0.08063813016210289
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00235294	0.08063813016210289
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00235294	0.08063813016210289
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00235294	0.08063813016210289
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00235294	0.08063813016210289
SILVER-RUSSELL SYNDROME	0.00235294	0.08063813016210289
SALIH MYOPATHY; SALMY	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00235294	0.08063813016210289
TEMPLE SYNDROME	0.00235294	0.08063813016210289
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00235294	0.08063813016210289
NEUTRAL LIPID STORAGE MYOPATHY	0.00235294	0.08063813016210289
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00235294	0.08063813016210289
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00235294	0.08063813016210289
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00235294	0.08063813016210289
MYOPATHY, CENTRONUCLEAR, 5	0.00235294	0.08063813016210289
NEMALINE MYOPATHY 4	0.00235294	0.08063813016210289
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00235294	0.08063813016210289
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00235294	0.08063813016210289
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00235294	0.08063813016210289
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.00235294	0.08063813016210289
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00235294	0.08063813016210289
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00235294	0.08063813016210289
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00235294	0.08063813016210289
260150 PALANT CLEFT PALATE SYNDROME	0.00235294	0.08063813016210289
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00235294	0.08063813016210289
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00235294	0.08063813016210289
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00235294	0.08063813016210289
USHER SYNDROME, TYPE IF	0.00235294	0.08063813016210289
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.08063813016210289
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00235294	0.08063813016210289
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00235294	0.08063813016210289
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00235294	0.08063813016210289
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00235294	0.08063813016210289
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00235294	0.08063813016210289
EPISODIC ATAXIA TYPE 1	0.00235294	0.08063813016210289
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00235294	0.08063813016210289
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00235294	0.08063813016210289
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00235294	0.08063813016210289
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00235294	0.08063813016210289
NEMALINE MYOPATHY 2; NEM2	0.00235294	0.08063813016210289
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00235294	0.08063813016210289
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00235294	0.08063813016210289
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00235294	0.08063813016210289
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00235294	0.08063813016210289
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00235294	0.08063813016210289
MENTAL RETARDATION, X-LINKED 19	0.00235294	0.08063813016210289
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00235294	0.08063813016210289
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA 13	0.00235294	0.08063813016210289
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00235294	0.08063813016210289
BETHLEM MYOPATHY 1	0.00235294	0.08063813016210289
NEMALINE MYOPATHY 1; NEM1	0.00235294	0.08063813016210289
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00235294	0.08063813016210289
BRUNNER SYNDROME; BRNRS	0.00235294	0.08063813016210289
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00235294	0.08063813016210289
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00235294	0.08063813016210289
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00235294	0.08063813016210289
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00235294	0.08063813016210289
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.00235294	0.08063813016210289
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00235294	0.08063813016210289
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00235294	0.08063813016210289
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00235294	0.08063813016210289
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00235294	0.08063813016210289
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.00235294	0.08063813016210289
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00235294	0.08063813016210289
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00235294	0.08063813016210289
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00235294	0.08063813016210289
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00235294	0.08063813016210289
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00235294	0.08063813016210289
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00235294	0.08063813016210289
NEMALINE MYOPATHY 3; NEM3	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00235294	0.08063813016210289
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.002350604	0.08055807258644918
NOONAN SYNDROME 9; NS9	0.002350604	0.08055807258644918
CREE MENTAL RETARDATION SYNDROME	0.002350604	0.08055807258644918
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002350604	0.08055807258644918
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.08055807258644918
CUTIS LAXA	0.002350604	0.08055807258644918
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.002350604	0.08055807258644918
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.002350604	0.08055807258644918
COLE-CARPENTER SYNDROME	0.002350604	0.08055807258644918
NOONAN SYNDROME 2; NS2	0.002350604	0.08055807258644918
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.08055807258644918
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.002350604	0.08055807258644918
17P13.3 MICRODUPLICATION SYNDROME	0.002350604	0.08055807258644918
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.002350604	0.08055807258644918
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.002350604	0.08055807258644918
FRIAS SYNDROME	0.002350604	0.08055807258644918
NOONAN SYNDROME 3; NS3	0.002350604	0.08055807258644918
TRISOMY 17P	0.002350604	0.08055807258644918
14Q22Q23 MICRODELETION SYNDROME	0.002350604	0.08055807258644918
CHROMOSOME 15Q25 DELETION SYNDROME	0.002350604	0.08055807258644918
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002350604	0.08055807258644918
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.002350604	0.08055807258644918
MEVALONIC ACIDURIA; MEVA	0.002350604	0.08055807258644918
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.002350604	0.08055807258644918
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002350604	0.08055807258644918
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.002350604	0.08055807258644918
RITSCHER-SCHINZEL SYNDROME 1	0.002350604	0.08055807258644918
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002350604	0.08055807258644918
XIA-GIBBS SYNDROME	0.002350604	0.08055807258644918
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002350604	0.08055807258644918
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002350604	0.08055807258644918
NOONAN SYNDROME 11; NS11	0.002350604	0.08055807258644918
NOONAN SYNDROME 5; NS5	0.002350604	0.08055807258644918
CHAR SYNDROME	0.002350604	0.08055807258644918
THAUVIN-ROBINET-FAIVRE SYNDROME	0.002350604	0.08055807258644918
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0023464690000000003	0.0804163610815998
LOWRY-MACLEAN SYNDROME	0.0023464690000000003	0.0804163610815998
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.0023464690000000003	0.0804163610815998
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0023464690000000003	0.0804163610815998
MALAN OVERGROWTH SYNDROME	0.0023464690000000003	0.0804163610815998
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0023464690000000003	0.0804163610815998
SMITH-FINEMAN-MYERS SYNDROME	0.0023464690000000003	0.0804163610815998
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0023464690000000003	0.0804163610815998
AUTISM, SUSCEPTIBILITY TO, 18	0.0023464690000000003	0.0804163610815998
MOMO SYNDROME	0.0023464690000000003	0.0804163610815998
ZIMMERMANN-LABAND SYNDROME	0.0023464690000000003	0.0804163610815998
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0023464690000000003	0.0804163610815998
ATKIN-FLAITZ SYNDROME	0.0023464690000000003	0.0804163610815998
PROTEUS SYNDROME	0.0023464690000000003	0.0804163610815998
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.0023464690000000003	0.0804163610815998
CLARK-BARAITSER SYNDROME	0.0023464690000000003	0.0804163610815998
2Q24 MICRODELETION SYNDROME	0.0023464690000000003	0.0804163610815998
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.0023464690000000003	0.0804163610815998
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.07022790362932246
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00204918	0.07022790362932246
WEYERS ACROFACIAL DYSOSTOSIS	0.00204918	0.07022790362932246
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.07022790362932246
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.07022790362932246
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00204918	0.07022790362932246
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.07022790362932246
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.07022790362932246
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.07022790362932246
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.07022790362932246
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.07022790362932246
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.07022790362932246
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.07022790362932246
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.07022790362932246
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00204918	0.07022790362932246
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.07022790362932246
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.07022790362932246
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.07022790362932246
AREDYLD SYNDROME	0.00204918	0.07022790362932246
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.07022790362932246
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.07022790362932246
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.07022790362932246
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.07022790362932246
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.07022790362932246
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.07022790362932246
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.07022790362932246
FRONTORHINY	0.00204918	0.07022790362932246
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.07022790362932246
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00204918	0.07022790362932246
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.07022790362932246
TETRALOGY OF FALLOT	0.00204918	0.07022790362932246
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.07022790362932246
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.07022790362932246
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00204918	0.07022790362932246
GREENBERG DYSPLASIA	0.00204918	0.07022790362932246
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.07022790362932246
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.07022790362932246
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00204918	0.07022790362932246
PYCNODYSOSTOSIS	0.00204918	0.07022790362932246
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.07022790362932246
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.07022790362932246
RADIO-RENAL SYNDROME	0.00204918	0.07022790362932246
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.07022790362932246
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00204918	0.07022790362932246
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.07022790362932246
RHYNS SYNDROME; RHYNS	0.00204918	0.07022790362932246
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.07022790362932246
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.07022790362932246
CLEIDOCRANIAL DYSPLASIA; CCD	0.00204918	0.07022790362932246
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.07022790362932246
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00204918	0.07022790362932246
WEILL-MARCHESANI SYNDROME	0.00204918	0.07022790362932246
LAURENCE-MOON SYNDROME	0.00204918	0.07022790362932246
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00204918	0.07022790362932246
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07022790362932246
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.07022790362932246
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00204918	0.07022790362932246
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.07022790362932246
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07022790362932246
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.07022790362932246
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.07022790362932246
PYCNODYSOSTOSIS	0.00204918	0.07022790362932246
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.07022790362932246
LARSEN SYNDROME	0.00204918	0.07022790362932246
CAMPTOBRACHYDACTYLY	0.00204918	0.07022790362932246
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.07022790362932246
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.07022790362932246
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.07022790362932246
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00204918	0.07022790362932246
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.07022790362932246
JEUNE SYNDROME	0.00204918	0.07022790362932246
GRANGE SYNDROME; GRNG	0.00204918	0.07022790362932246
BRACHYDACTYLY, TYPE E	0.00204918	0.07022790362932246
OPSISMODYSPLASIA	0.00204918	0.07022790362932246
CLEIDOCRANIAL DYSPLASIA	0.00204918	0.07022790362932246
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.07022790362932246
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00204918	0.07022790362932246
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.07022790362932246
METATROPIC DYSPLASIA	0.00204918	0.07022790362932246
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00204918	0.07022790362932246
COOKS SYNDROME	0.00204918	0.07022790362932246
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.07022790362932246
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.07022790362932246
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.07022790362932246
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00204918	0.07022790362932246
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.07022790362932246
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.07022790362932246
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.07022790362932246
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.07022790362932246
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.07022790362932246
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.07022790362932246
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.07022790362932246
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.07022790362932246
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.07022790362932246
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.07022790362932246
CHITAYAT SYNDROME	0.00204918	0.07022790362932246
2Q37 MONOSOMY	0.00204918	0.07022790362932246
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.07022790362932246
HYPOCHONDROPLASIA	0.00204918	0.07022790362932246
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.07022790362932246
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.07022790362932246
OROFACIODIGITAL SYNDROME IV; OFD4	0.00204918	0.07022790362932246
ATELOSTEOGENESIS TYPE II	0.00204918	0.07022790362932246
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.07022790362932246
SILLENCE SYNDROME	0.00204918	0.07022790362932246
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.07022790362932246
EIKEN SYNDROME	0.00204918	0.07022790362932246
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.07022790362932246
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.07022790362932246
ACROMICRIC DYSPLASIA	0.00204918	0.07022790362932246
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.07022790362932246
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.07022790362932246
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.07022790362932246
FEINGOLD SYNDROME	0.00204918	0.07022790362932246
JACOBSEN SYNDROME	0.00204918	0.07022790362932246
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.07022790362932246
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.07022790362932246
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.07022790362932246
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.07022790362932246
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.07022790362932246
ROIFMAN SYNDROME	0.00204918	0.07022790362932246
HEART-HAND SYNDROME TYPE 2	0.00204918	0.07022790362932246
HEART-HAND SYNDROME TYPE 3	0.00204918	0.07022790362932246
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.07022790362932246
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00204918	0.07022790362932246
EMERY-NELSON SYNDROME	0.00204918	0.07022790362932246
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.07022790362932246
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.07022790362932246
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.07022790362932246
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.07022790362932246
ENG-STROM SYNDROME	0.00204918	0.07022790362932246
SUMMITT SYNDROME	0.00204918	0.07022790362932246
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00204918	0.07022790362932246
CAMPTOBRACHYDACTYLY	0.00204918	0.07022790362932246
CAMPOMELIA, CUMMING TYPE	0.00204918	0.07022790362932246
SMITH-MAGENIS SYNDROME	0.00204918	0.07022790362932246
CRANIOECTODERMAL DYSPLASIA	0.00204918	0.07022790362932246
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.07022790362932246
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.07022790362932246
ABRUZZO-ERICKSON SYNDROME	0.00204918	0.07022790362932246
PERIPHERAL DYSOSTOSIS	0.00204918	0.07022790362932246
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.07022790362932246
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.07022790362932246
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.07022790362932246
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.07022790362932246
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.07022790362932246
ISOLATED BRACHYCEPHALY	0.00204918	0.07022790362932246
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.07022790362932246
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.07022790362932246
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.07022790362932246
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.07022790362932246
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.07022790362932246
SATOYOSHI SYNDROME	0.00204918	0.07022790362932246
SYMPHALANGISM, DISTAL	0.00204918	0.07022790362932246
SYNDACTYLY, TYPE V	0.00204918	0.07022790362932246
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.07022790362932246
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.07022790362932246
PROXIMAL SYMPHALANGISM	0.00204918	0.07022790362932246
LOWRY-WOOD SYNDROME	0.00204918	0.07022790362932246
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.07022790362932246
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00204918	0.07022790362932246
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.07022790362932246
PSEUDOACHONDROPLASIA	0.00204918	0.07022790362932246
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.07022790362932246
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.07022790362932246
HYPOCHONDROPLASIA	0.00204918	0.07022790362932246
BANKI SYNDROME	0.00204918	0.07022790362932246
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.07022790362932246
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00196464	0.06733061448301864
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.06733061448301864
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.06733061448301864
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.06733061448301864
MULIBREY NANISM	0.00196464	0.06733061448301864
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00196464	0.06733061448301864
FRONTONASAL DYSPLASIA	0.00196464	0.06733061448301864
VELO-FACIAL-SKELETAL SYNDROME	0.00196464	0.06733061448301864
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.06733061448301864
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00196464	0.06733061448301864
3Q13 MICRODELETION SYNDROME	0.00196464	0.06733061448301864
MEGALENCEPHALY	0.00196464	0.06733061448301864
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00196464	0.06733061448301864
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00196464	0.06733061448301864
BEEMER LETHAL MALFORMATION SYNDROME	0.00196464	0.06733061448301864
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00196464	0.06733061448301864
BOOMERANG DYSPLASIA	0.00196464	0.06733061448301864
FEINGOLD SYNDROME 1; FGLDS1	0.00196464	0.06733061448301864
RING CHROMOSOME 13 SYNDROME	0.00196464	0.06733061448301864
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00196464	0.06733061448301864
MARSHALL SYNDROME	0.00196464	0.06733061448301864
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.06733061448301864
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.06733061448301864
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00196464	0.06733061448301864
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00196464	0.06733061448301864
49,XXXYY SYNDROME	0.00196464	0.06733061448301864
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.06733061448301864
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00196464	0.06733061448301864
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00196464	0.06733061448301864
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00196464	0.06733061448301864
HAMAMY SYNDROME; HMMS	0.00196464	0.06733061448301864
JUNG SYNDROME	0.00196464	0.06733061448301864
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.06733061448301864
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.06733061448301864
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.06733061448301864
DUBOWITZ SYNDROME	0.00196464	0.06733061448301864
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00196464	0.06733061448301864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.06733061448301864
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00196464	0.06733061448301864
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00196464	0.06733061448301864
SHELDON-HALL SYNDROME	0.00196464	0.06733061448301864
RETINITIS PIGMENTOSA	0.00196464	0.06733061448301864
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.06733061448301864
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.06733061448301864
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.06733061448301864
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.06733061448301864
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.06733061448301864
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.06733061448301864
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00196464	0.06733061448301864
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.06733061448301864
MECKEL SYNDROME 12; MKS12	0.00196464	0.06733061448301864
AXENFELD-RIEGER SYNDROME	0.00196464	0.06733061448301864
FACIOCARDIORENAL SYNDROME	0.00196464	0.06733061448301864
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.06733061448301864
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.06733061448301864
FACIOCARDIORENAL SYNDROME	0.00196464	0.06733061448301864
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.06733061448301864
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.06733061448301864
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00196464	0.06733061448301864
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06733061448301864
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00196464	0.06733061448301864
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00196464	0.06733061448301864
SCLEROSTEOSIS 1; SOST1	0.00196464	0.06733061448301864
ZECHI-CEIDE SYNDROME	0.00196464	0.06733061448301864
RING CHROMOSOME 6 SYNDROME	0.00196464	0.06733061448301864
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.06733061448301864
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.06733061448301864
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.06733061448301864
ISOLATED TRIGONOCEPHALY	0.00196464	0.06733061448301864
SHORT SYNDROME	0.00196464	0.06733061448301864
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06733061448301864
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.06733061448301864
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.06733061448301864
PIEBALDISM	0.00196464	0.06733061448301864
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.06733061448301864
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00196464	0.06733061448301864
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.06733061448301864
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00196464	0.06733061448301864
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.06733061448301864
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.06733061448301864
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00180505	0.061861270091504175
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00180505	0.061861270091504175
TREACHER COLLINS SYNDROME 2; TCS2	0.00180505	0.061861270091504175
2P15-16.1 MICRODELETION SYNDROME	0.00180505	0.061861270091504175
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00180505	0.061861270091504175
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00180505	0.061861270091504175
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00180505	0.061861270091504175
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00180505	0.061861270091504175
8Q21.11 MICRODELETION SYNDROME	0.00180505	0.061861270091504175
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00180505	0.061861270091504175
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.061861270091504175
RUVALCABA SYNDROME	0.00180505	0.061861270091504175
PHAVER SYNDROME	0.00180505	0.061861270091504175
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.061861270091504175
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.061861270091504175
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.061861270091504175
LEGIUS SYNDROME	0.00180505	0.061861270091504175
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00180505	0.061861270091504175
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00180505	0.061861270091504175
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00180505	0.061861270091504175
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00180505	0.061861270091504175
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00180505	0.061861270091504175
ALAGILLE SYNDROME	0.00180505	0.061861270091504175
MEESTER-LOEYS SYNDROME; MRLS	0.00180505	0.061861270091504175
THOMAS SYNDROME	0.00180505	0.061861270091504175
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00180505	0.061861270091504175
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00180505	0.061861270091504175
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00180505	0.061861270091504175
ACRORENAL-MANDIBULAR SYNDROME	0.00180505	0.061861270091504175
ACROOTOOCULAR SYNDROME	0.00180505	0.061861270091504175
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00180505	0.061861270091504175
MARFAN SYNDROME; MFS	0.00180505	0.061861270091504175
PROTEUS-LIKE SYNDROME	0.00180505	0.061861270091504175
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00180505	0.061861270091504175
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00180505	0.061861270091504175
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00180505	0.061861270091504175
NOONAN SYNDROME 4; NS4	0.00180505	0.061861270091504175
CENANI-LENZ SYNDROME	0.00180505	0.061861270091504175
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00180505	0.061861270091504175
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.00180505	0.061861270091504175
DIAMOND-BLACKFAN ANEMIA 1	0.00180505	0.061861270091504175
JUVENILE POLYPOSIS SYNDROME	0.00180505	0.061861270091504175
MESOMELIA-SYNOSTOSES SYNDROME	0.00180505	0.061861270091504175
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.00180505	0.061861270091504175
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00180505	0.061861270091504175
MARFAN SYNDROME	0.00180505	0.061861270091504175
TRISOMY 1Q	0.00180505	0.061861270091504175
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00180505	0.061861270091504175
CAT-EYE SYNDROME	0.00180505	0.061861270091504175
ACRO-RENAL-MANDIBULAR SYNDROME	0.00180505	0.061861270091504175
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00180505	0.061861270091504175
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.061861270091504175
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00180505	0.061861270091504175
NON-DISTAL TRISOMY 10Q	0.00180505	0.061861270091504175
PAI SYNDROME	0.00180505	0.061861270091504175
NOONAN SYNDROME 8; NS8	0.00180505	0.061861270091504175
WAARDENBURG SYNDROME TYPE 3	0.00180505	0.061861270091504175
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00180505	0.061861270091504175
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00180505	0.061861270091504175
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00180505	0.061861270091504175
SECKEL SYNDROME	0.00180505	0.061861270091504175
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.061861270091504175
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.061861270091504175
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00180505	0.061861270091504175
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00180505	0.061861270091504175
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00180505	0.061861270091504175
RESTRICTIVE DERMOPATHY	0.00180505	0.061861270091504175
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.061861270091504175
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00180505	0.061861270091504175
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00180505	0.061861270091504175
NAGER SYNDROME	0.00180505	0.061861270091504175
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00180505	0.061861270091504175
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.061861270091504175
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00180505	0.061861270091504175
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00180505	0.061861270091504175
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.061861270091504175
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00180505	0.061861270091504175
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00180505	0.061861270091504175
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00180505	0.061861270091504175
NOONAN SYNDROME 10; NS10	0.00180505	0.061861270091504175
APERT SYNDROME	0.00180505	0.061861270091504175
GMS SYNDROME	0.00180505	0.061861270091504175
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00180505	0.061861270091504175
FRONTOMETAPHYSEAL DYSPLASIA	0.00180505	0.061861270091504175
HARTSFIELD SYNDROME	0.00180505	0.061861270091504175
JOHNSON NEUROECTODERMAL SYNDROME	0.00180505	0.061861270091504175
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.061861270091504175
PRIMROSE SYNDROME; PRIMS	0.00180505	0.061861270091504175
ANTLEY-BIXLER SYNDROME	0.00180505	0.061861270091504175
TREACHER COLLINS SYNDROME 3; TCS3	0.00180505	0.061861270091504175
CEREBROFACIOTHORACIC DYSPLASIA	0.00180505	0.061861270091504175
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.03725189348504062
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.03725189348504062
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.03725189348504062
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.03725189348504062
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.03725189348504062
LEIGH SYNDROME; LS	0.001086973	0.03725189348504062
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001086973	0.03725189348504062
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03725189348504062
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.03725189348504062
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.03725189348504062
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.03725189348504062
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.001086973	0.03725189348504062
SRD5A3-CDG	0.001086973	0.03725189348504062
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03725189348504062
SALLA DISEASE	0.001086973	0.03725189348504062
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03725189348504062
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.03725189348504062
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.03725189348504062
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03725189348504062
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.03725189348504062
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.03725189348504062
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03725189348504062
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.03725189348504062
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.03725189348504062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.03725189348504062
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.03725189348504062
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.03725189348504062
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.03725189348504062
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.03725189348504062
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.03725189348504062
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.03725189348504062
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.03725189348504062
OPTIC PATHWAY GLIOMA	0.001086973	0.03725189348504062
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.03725189348504062
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.03725189348504062
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.03725189348504062
PIERPONT SYNDROME	0.001086973	0.03725189348504062
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.03725189348504062
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.03725189348504062
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.03725189348504062
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.03725189348504062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.03725189348504062
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.03725189348504062
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03725189348504062
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.03725189348504062
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.03725189348504062
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.03725189348504062
WALKER-WARBURG SYNDROME	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.03725189348504062
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.03725189348504062
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.03725189348504062
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.03725189348504062
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.03725189348504062
EAST SYNDROME	0.001086973	0.03725189348504062
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.03725189348504062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.03725189348504062
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.03725189348504062
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.03725189348504062
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.03725189348504062
48,XXYY SYNDROME	0.001086973	0.03725189348504062
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.03725189348504062
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03725189348504062
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.03725189348504062
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.03725189348504062
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.03725189348504062
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.03725189348504062
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.03725189348504062
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.03725189348504062
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001086973	0.03725189348504062
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.03725189348504062
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.03725189348504062
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.03725189348504062
HOLOPROSENCEPHALY 7	0.001086973	0.03725189348504062
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.03725189348504062
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.03725189348504062
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.03725189348504062
KBG SYNDROME	0.001086973	0.03725189348504062
EMANUEL SYNDROME	0.001086973	0.03725189348504062
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.03725189348504062
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.03725189348504062
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.03725189348504062
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.03725189348504062
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.03725189348504062
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.03725189348504062
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03725189348504062
DISTAL MONOSOMY 1Q	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.03725189348504062
COFFIN-SIRIS SYNDROME 5	0.001086973	0.03725189348504062
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.03725189348504062
SCHINDLER DISEASE, TYPE I	0.001086973	0.03725189348504062
PALLISTER-HALL SYNDROME	0.001086973	0.03725189348504062
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03725189348504062
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.03725189348504062
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03725189348504062
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.03725189348504062
STT3A-CDG	0.001086973	0.03725189348504062
STT3B-CDG	0.001086973	0.03725189348504062
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03725189348504062
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03725189348504062
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.03725189348504062
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.03725189348504062
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03725189348504062
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.03725189348504062
KAGAMI-OGATA SYNDROME	0.001086973	0.03725189348504062
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.03725189348504062
XQ21 MICRODELETION SYNDROME	0.001086973	0.03725189348504062
RING CHROMOSOME 22 SYNDROME	0.001086973	0.03725189348504062
GRISCELLI SYNDROME	0.001086973	0.03725189348504062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.03725189348504062
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.03725189348504062
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.03725189348504062
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.03725189348504062
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.03725189348504062
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.03725189348504062
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.03725189348504062
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.03725189348504062
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.03725189348504062
SSR4-CDG	0.001086973	0.03725189348504062
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.03725189348504062
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.03725189348504062
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.03725189348504062
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.03725189348504062
DISTAL TRISOMY 17Q	0.001086973	0.03725189348504062
TRISOMY X	0.001086973	0.03725189348504062
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.03725189348504062
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03725189348504062
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.03725189348504062
PHACE ASSOCIATION	0.001086973	0.03725189348504062
DPAGT1-CDG	0.001086973	0.03725189348504062
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.03725189348504062
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.03725189348504062
GAUCHER DISEASE, TYPE II	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03725189348504062
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.03725189348504062
PROPIONIC ACIDEMIA	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.03725189348504062
ISOVALERIC ACIDEMIA	0.001086973	0.03725189348504062
PFEIFFER SYNDROME TYPE 2	0.001086973	0.03725189348504062
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.03725189348504062
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.03725189348504062
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.03725189348504062
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.03725189348504062
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.03725189348504062
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.03725189348504062
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.03725189348504062
HARTNUP DISORDER	0.001086973	0.03725189348504062
KEUTEL SYNDROME	0.001086973	0.03725189348504062
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.03725189348504062
2P21 MICRODELETION SYNDROME	0.001086973	0.03725189348504062
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.03725189348504062
PHACE SYNDROME	0.001086973	0.03725189348504062
GALACTOSEMIA	0.001086973	0.03725189348504062
LISSENCEPHALY 1; LIS1	0.001086973	0.03725189348504062
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.03725189348504062
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03725189348504062
FUCOSIDOSIS	0.001086973	0.03725189348504062
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.03725189348504062
WILSON-TURNER SYNDROME	0.001086973	0.03725189348504062
ELEJALDE DISEASE	0.001086973	0.03725189348504062
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.001086973	0.03725189348504062
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.03725189348504062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.03725189348504062
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03725189348504062
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.03725189348504062
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.03725189348504062
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.03725189348504062
AICARDI-GOUTIERES SYNDROME 7	0.001086973	0.03725189348504062
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.03725189348504062
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.03725189348504062
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03725189348504062
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.03725189348504062
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.03725189348504062
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.03725189348504062
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.03725189348504062
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.03725189348504062
RFT1-CDG	0.001086973	0.03725189348504062
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.03725189348504062
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.03725189348504062
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.03725189348504062
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.03725189348504062
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.03725189348504062
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.03725189348504062
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.03725189348504062
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.03725189348504062
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.03725189348504062
CITRULLINEMIA TYPE II	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.03725189348504062
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001086973	0.03725189348504062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03725189348504062
LISSENCEPHALY 4	0.001086973	0.03725189348504062
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.03725189348504062
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03725189348504062
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03725189348504062
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.03725189348504062
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03725189348504062
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03725189348504062
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.03725189348504062
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.03725189348504062
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.03725189348504062
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.03725189348504062
WYBURN-MASON SYNDROME	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.03725189348504062
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.03725189348504062
CLASSIC PHENYLKETONURIA	0.001086973	0.03725189348504062
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03725189348504062
CRANIOPHARYNGIOMA	0.001086973	0.03725189348504062
HYDRANENCEPHALY	0.001086973	0.03725189348504062
BAND HETEROTOPIA; BH	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.03725189348504062
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03725189348504062
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03725189348504062
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.03725189348504062
COACH SYNDROME	0.001086973	0.03725189348504062
CITRULLINEMIA, CLASSIC	0.001086973	0.03725189348504062
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.03725189348504062
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.03725189348504062
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.03725189348504062
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001086973	0.03725189348504062
LEBER CONGENITAL AMAUROSIS	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.03725189348504062
PETTIGREW SYNDROME	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.03725189348504062
19P13.12 MICRODELETION SYNDROME	0.001086973	0.03725189348504062
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.03725189348504062
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.03725189348504062
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.03725189348504062
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.03725189348504062
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001086973	0.03725189348504062
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.03725189348504062
ALG3-CDG	0.001086973	0.03725189348504062
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.03725189348504062
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.03725189348504062
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.03725189348504062
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.03725189348504062
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.03725189348504062
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.03725189348504062
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03725189348504062
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03725189348504062
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.03725189348504062
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.03725189348504062
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.03725189348504062
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.03725189348504062
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.03725189348504062
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.03725189348504062
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.03725189348504062
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.03725189348504062
ALG1-CDG	0.001086973	0.03725189348504062
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03725189348504062
NETHERTON SYNDROME	0.001086973	0.03725189348504062
XP21 MICRODELETION SYNDROME	0.001086973	0.03725189348504062
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.03725189348504062
SULFOCYSTEINURIA	0.001086973	0.03725189348504062
WAISMAN SYNDROME; WSMN	0.001086973	0.03725189348504062
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.03725189348504062
ALSTRÖM SYNDROME	0.001086973	0.03725189348504062
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.03725189348504062
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.03725189348504062
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03725189348504062
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.03725189348504062
NARP SYNDROME	0.001086973	0.03725189348504062
17Q12 MICRODELETION SYNDROME	0.001086973	0.03725189348504062
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03725189348504062
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.03725189348504062
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.03725189348504062
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.03725189348504062
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.03725189348504062
AICARDI-GOUTIÈRES SYNDROME	0.001086973	0.03725189348504062
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.03725189348504062
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03725189348504062
ARGININOSUCCINIC ACIDURIA	0.001086973	0.03725189348504062
EMANUEL SYNDROME	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.03725189348504062
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.03725189348504062
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.03725189348504062
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.03725189348504062
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.03725189348504062
TIMOTHY SYNDROME; TS	0.001086973	0.03725189348504062
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03725189348504062
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03725189348504062
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.03725189348504062
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.03725189348504062
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.03725189348504062
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.03725189348504062
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.03725189348504062
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03725189348504062
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03725189348504062
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03725189348504062
MAPLE SYRUP URINE DISEASE	0.001086973	0.03725189348504062
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.03725189348504062
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.03725189348504062
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.03725189348504062
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.03725189348504062
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.03725189348504062
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.03725189348504062
MACDERMOT-WINTER SYNDROME	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.03725189348504062
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.03725189348504062
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.03725189348504062
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.03725189348504062
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.03725189348504062
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03725189348504062
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.03725189348504062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.03725189348504062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.03725189348504062
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.03725189348504062
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.03725189348504062
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.03725189348504062
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.03725189348504062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.03725189348504062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.03725189348504062
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.03725189348504062
XQ25 DUPLICATION SYNDROME	0.001086973	0.03725189348504062
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.03725189348504062
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.03725189348504062
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.03725189348504062
CONGENITAL TOXOPLASMOSIS	0.001086973	0.03725189348504062
MEDULLOBLASTOMA	0.000545554	0.018696802494944997
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.018696802494944997
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.018696802494944997
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.018696802494944997
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.018696802494944997
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.018696802494944997
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.018696802494944997
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.018696802494944997
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.018696802494944997
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.018696802494944997
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.018696802494944997
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.018696802494944997
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.018696802494944997
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.018696802494944997
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.018696802494944997
BRESEK SYNDROME	0.000545554	0.018696802494944997
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.018696802494944997
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.018696802494944997
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.018696802494944997
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.018696802494944997
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.018696802494944997
CURRY-JONES SYNDROME	0.000545554	0.018696802494944997
AURICULOCONDYLAR SYNDROME	0.000545554	0.018696802494944997
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.018696802494944997
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.018696802494944997
TRANSKETOLASE DEFICIENCY	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.018696802494944997
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.018696802494944997
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.018696802494944997
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.018696802494944997
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.018696802494944997
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.018696802494944997
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.018696802494944997
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.018696802494944997
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.018696802494944997
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.018696802494944997
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.018696802494944997
MUCOLIPIDOSIS IV; ML4	0.000545554	0.018696802494944997
JOUBERT SYNDROME 2	0.000545554	0.018696802494944997
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.018696802494944997
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.018696802494944997
48,XYYY SYNDROME	0.000545554	0.018696802494944997
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.018696802494944997
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.018696802494944997
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.018696802494944997
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.018696802494944997
NAVAJO NEUROHEPATOPATHY	0.000545554	0.018696802494944997
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.018696802494944997
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.018696802494944997
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.018696802494944997
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.018696802494944997
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.018696802494944997
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.018696802494944997
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.018696802494944997
NETHERTON SYNDROME; NETH	0.000545554	0.018696802494944997
MECKEL SYNDROME 13; MKS13	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.018696802494944997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.018696802494944997
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.018696802494944997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.018696802494944997
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.018696802494944997
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.018696802494944997
ARIMA SYNDROME	0.000545554	0.018696802494944997
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.018696802494944997
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.018696802494944997
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.018696802494944997
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.018696802494944997
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.018696802494944997
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.018696802494944997
TRANSALDOLASE DEFICIENCY	0.000545554	0.018696802494944997
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.018696802494944997
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.018696802494944997
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.018696802494944997
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.018696802494944997
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.018696802494944997
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.018696802494944997
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.018696802494944997
LIG4 SYNDROME	0.000545554	0.018696802494944997
LOWRY-MACLEAN SYNDROME	0.000545554	0.018696802494944997
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.018696802494944997
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.018696802494944997
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.018696802494944997
OPTIC ATROPHY 11; OPA11	0.000545554	0.018696802494944997
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.018696802494944997
JAWAD SYNDROME	0.000545554	0.018696802494944997
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.018696802494944997
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.018696802494944997
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.018696802494944997
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.018696802494944997
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.018696802494944997
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.018696802494944997
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.018696802494944997
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.018696802494944997
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.018696802494944997
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.018696802494944997
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.018696802494944997
CDAGS SYNDROME	0.000545554	0.018696802494944997
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.018696802494944997
8P23.1 DUPLICATION SYNDROME	0.000545554	0.018696802494944997
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.018696802494944997
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.018696802494944997
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.018696802494944997
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.018696802494944997
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.018696802494944997
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.018696802494944997
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.018696802494944997
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.018696802494944997
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.018696802494944997
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.018696802494944997
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.018696802494944997
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.018696802494944997
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.018696802494944997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.018696802494944997
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.018696802494944997
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.018696802494944997
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.018696802494944997
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.018696802494944997
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.018696802494944997
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944997
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.018696802494944997
CONGENITAL VARICELLA SYNDROME	0.000545554	0.018696802494944997
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.018696802494944997
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944997
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.018696802494944997
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.018696802494944997
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.018696802494944997
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.018696802494944997
JOUBERT SYNDROME 21	0.000545554	0.018696802494944997
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.018696802494944997
1P21.3 MICRODELETION SYNDROME	0.000545554	0.018696802494944997
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.018696802494944997
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.018696802494944997
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.018696802494944997
ALSTROM SYNDROME; ALMS	0.000545554	0.018696802494944997
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.018696802494944997
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.018696802494944997
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.018696802494944997
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.018696802494944997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.018696802494944997
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.018696802494944997
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.018696802494944997
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018696802494944997
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.018696802494944997
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.018696802494944997
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.018696802494944997
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.018696802494944997
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.018696802494944997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.018696802494944997
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.018696802494944997
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.018696802494944997
HYDROXYKYNURENINURIA	0.000545554	0.018696802494944997
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.018696802494944997
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.018696802494944997
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.018696802494944997
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.018696802494944997
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.018696802494944997
GERODERMA OSTEODYSPLASTICA	0.000545554	0.018696802494944997
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.018696802494944997
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.018696802494944997
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.018696802494944997
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.018696802494944997
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.018696802494944997
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.018696802494944997
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.018696802494944997
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.018696802494944997
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.018696802494944997
WAARDENBURG-SHAH SYNDROME	0.000545554	0.018696802494944997
BARDET-BIEDL SYNDROME 2	0.000545554	0.018696802494944997
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.018696802494944997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.018696802494944997
CULLER-JONES SYNDROME; CJS	0.000545554	0.018696802494944997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.018696802494944997
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.018696802494944997
SECKEL SYNDROME 8; SCKL8	0.000545554	0.018696802494944997
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.018696802494944997
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.018696802494944997
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.018696802494944997
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.018696802494944997
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.018696802494944997
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.018696802494944997
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.018696802494944997
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.018696802494944997
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.018696802494944997
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.018696802494944997
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.018696802494944997
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.018696802494944997
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.018696802494944997
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.018696802494944997
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.018696802494944997
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944997
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.018696802494944997
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.018696802494944997
MARDEN-WALKER SYNDROME	0.000545554	0.018696802494944997
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.018696802494944997
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.018696802494944997
HOLOPROSENCEPHALY 11	0.000545554	0.018696802494944997
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.018696802494944997
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.018696802494944997
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.018696802494944997
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.018696802494944997
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.018696802494944997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.018696802494944997
JOUBERT SYNDROME 15	0.000545554	0.018696802494944997
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.018696802494944997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.018696802494944997
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.018696802494944997
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.018696802494944997
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.018696802494944997
N SYNDROME	0.000545554	0.018696802494944997
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.018696802494944997
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.018696802494944997
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.018696802494944997
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.018696802494944997
TYSHCHENKO SYNDROME	0.000545554	0.018696802494944997
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.018696802494944997
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.018696802494944997
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944997
MICROVILLUS INCLUSION DISEASE	0.000545554	0.018696802494944997
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.018696802494944997
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.018696802494944997
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.018696802494944997
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.018696802494944997
USHER SYNDROME TYPE 1	0.000545554	0.018696802494944997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.018696802494944997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.018696802494944997
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.018696802494944997
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.018696802494944997
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.018696802494944997
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.018696802494944997
OTOFACIOCERVICAL SYNDROME	0.000545554	0.018696802494944997
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.018696802494944997
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.018696802494944997
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.018696802494944997
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.018696802494944997
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.018696802494944997
AUSTRALIA ANTIGEN	0.000545554	0.018696802494944997
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.018696802494944997
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.018696802494944997
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.018696802494944997
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.018696802494944997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.018696802494944997
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.018696802494944997
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.018696802494944997
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.018696802494944997
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.018696802494944997
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.018696802494944997
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.018696802494944997
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.018696802494944997
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.018696802494944997
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.018696802494944997
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.018696802494944997
YUNIS-VARON SYNDROME	0.000545554	0.018696802494944997
ALG6-CDG	0.000545554	0.018696802494944997
DEXTROCARDIA	0.000545554	0.018696802494944997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.018696802494944997
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.018696802494944997
HYDROXYKYNURENINURIA	0.000545554	0.018696802494944997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.018696802494944997
TRISOMY 18	0.000545554	0.018696802494944997
JOUBERT SYNDROME 26	0.000545554	0.018696802494944997
JOUBERT SYNDROME 25	0.000545554	0.018696802494944997
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.018696802494944997
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.018696802494944997
MEIER-GORLIN SYNDROME 7	0.000545554	0.018696802494944997
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.018696802494944997
CHAR SYNDROME	0.000545554	0.018696802494944997
FARBER DISEASE	0.000545554	0.018696802494944997
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.018696802494944997
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.018696802494944997
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.018696802494944997
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.018696802494944997
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.018696802494944997
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.018696802494944997
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.018696802494944997
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.018696802494944997
DYSKERATOSIS CONGENITA	0.000545554	0.018696802494944997
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.018696802494944997
PROPIONIC ACIDEMIA	0.000545554	0.018696802494944997
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.018696802494944997
ISOLATED PLAGIOCEPHALY	0.000545554	0.018696802494944997
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.018696802494944997
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.018696802494944997
THYROID HYPOPLASIA	0.000545554	0.018696802494944997
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.018696802494944997
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.018696802494944997
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.018696802494944997
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.018696802494944997
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.018696802494944997
WOLMAN DISEASE	0.000545554	0.018696802494944997
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.018696802494944997
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.018696802494944997
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.018696802494944997
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.018696802494944997
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.018696802494944997
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.018696802494944997
EVEN-PLUS SYNDROME	0.000545554	0.018696802494944997
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.018696802494944997
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.018696802494944997
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.018696802494944997
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.018696802494944997
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.018696802494944997
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018696802494944997
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.018696802494944997
EPIDERMAL NEVUS SYNDROME	0.000545554	0.018696802494944997
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.018696802494944997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.018696802494944997
JOUBERT SYNDROME 6	0.000545554	0.018696802494944997
SENIOR-LOKEN SYNDROME 9	0.000545554	0.018696802494944997
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.018696802494944997
JOUBERT SYNDROME 27	0.000545554	0.018696802494944997
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.018696802494944997
JOUBERT SYNDROME 7	0.000545554	0.018696802494944997
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.018696802494944997
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.018696802494944997
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.018696802494944997
RIGID SPINE SYNDROME	0.000545554	0.018696802494944997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.018696802494944997
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.018696802494944997
JOUBERT SYNDROME 28	0.000545554	0.018696802494944997
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.018696802494944997
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.018696802494944997
ATHYREOSIS	0.000545554	0.018696802494944997
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.018696802494944997
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.018696802494944997
SENIOR-LOKEN SYNDROME	0.000545554	0.018696802494944997
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.018696802494944997
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.018696802494944997
ZEBRA BODY MYOPATHY	0.000545554	0.018696802494944997
JOUBERT SYNDROME 8	0.000545554	0.018696802494944997
OROTIC ACIDURIA	0.000545554	0.018696802494944997
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.018696802494944997
REVESZ SYNDROME	0.000545554	0.018696802494944997
SEPTOOPTIC DYSPLASIA	0.000545554	0.018696802494944997
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944997
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.018696802494944997
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.018696802494944997
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.018696802494944997
PELLAGRA-LIKE SYNDROME	0.000545554	0.018696802494944997
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.018696802494944997
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.018696802494944997
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.018696802494944997
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.018696802494944997
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.018696802494944997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.018696802494944997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.018696802494944997
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.018696802494944997
300270 ADRENOMYODYSTROPHY	0.000545554	0.018696802494944997
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.018696802494944997
RING CHROMOSOME 12 SYNDROME	0.000545554	0.018696802494944997
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.018696802494944997
TOLUENE EMBRYOPATHY	0.000545554	0.018696802494944997
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.018696802494944997
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.018696802494944997
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.018696802494944997
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.018696802494944997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.018696802494944997
CURRARINO SYNDROME	0.000545554	0.018696802494944997
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.018696802494944997
PORPHYRIA	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.01855509099009562
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.01855509099009562
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.01855509099009562
TRIPLE A SYNDROME	0.000541419	0.01855509099009562
DPM1-CDG	0.000541419	0.01855509099009562
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.01855509099009562
ALG2-CDG	0.000541419	0.01855509099009562
MPDU1-CDG	0.000541419	0.01855509099009562
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.01855509099009562
ADDISON DISEASE	0.000541419	0.01855509099009562
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.01855509099009562
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.01855509099009562
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.01855509099009562
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.01855509099009562
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.01855509099009562
MOGS-CDG	0.000541419	0.01855509099009562
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.01855509099009562
ALG9-CDG	0.000541419	0.01855509099009562
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.01855509099009562
HADDAD SYNDROME	0.000541419	0.01855509099009562
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.01855509099009562
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.01855509099009562
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.01855509099009562
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.01855509099009562
GRISCELLI SYNDROME TYPE 2	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.01855509099009562
COG8-CDG	0.000541419	0.01855509099009562
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.01855509099009562
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.01855509099009562
NIPAH VIRUS DISEASE	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.01855509099009562
EPISODIC ATAXIA TYPE 3	0.000541419	0.01855509099009562
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.01855509099009562
SJÖGREN-LARSSON SYNDROME	0.000541419	0.01855509099009562
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.01855509099009562
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.01855509099009562
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.01855509099009562
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.01855509099009562
FAMILIAL THROMBOCYTOSIS	0.000541419	0.01855509099009562
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.01855509099009562
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.01855509099009562
ADRENOMYODYSTROPHY	0.000541419	0.01855509099009562
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.01855509099009562
ENCEPHALITIS LETHARGICA	0.000541419	0.01855509099009562
FRAGILE X SYNDROME	0.000541419	0.01855509099009562
HEREDITARY COPROPORPHYRIA	0.000541419	0.01855509099009562
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.01855509099009562
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.01855509099009562
SYSTEMIC SCLEROSIS	0.000541419	0.01855509099009562
FETAL GAUCHER DISEASE	0.000541419	0.01855509099009562
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.01855509099009562
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.01855509099009562
SECONDARY SYRINGOMYELIA	0.000541419	0.01855509099009562
PFEIFFER SYNDROME TYPE 3	0.000541419	0.01855509099009562
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.01855509099009562
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.01855509099009562
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.01855509099009562
INSULINOMA	0.000541419	0.01855509099009562
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.01855509099009562
PORPHYRIA VARIEGATA	0.000541419	0.01855509099009562
SCRUB TYPHUS	0.000541419	0.01855509099009562
LASSA FEVER	0.000541419	0.01855509099009562
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.01855509099009562
ONDINE SYNDROME	0.000541419	0.01855509099009562
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.01855509099009562
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.01855509099009562
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.01855509099009562
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.01855509099009562
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.01855509099009562
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.01855509099009562
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.01855509099009562
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.01855509099009562
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.01855509099009562
GURRIERI SYNDROME	0.000541419	0.01855509099009562
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.01855509099009562
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.01855509099009562
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.01855509099009562
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.01855509099009562
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.01855509099009562
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.01855509099009562
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.01855509099009562
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.01855509099009562
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.01855509099009562
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.01855509099009562
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.01855509099009562
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.01855509099009562
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.01855509099009562
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.01855509099009562
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.01855509099009562
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.01855509099009562
THREONINEMIA	0.000541419	0.01855509099009562
THYROCEREBRORETINAL SYNDROME	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.01855509099009562
ADRENOLEUKODYSTROPHY	0.000541419	0.01855509099009562
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.01855509099009562
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.01855509099009562
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.01855509099009562
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.01855509099009562
INCONTINENTIA PIGMENTI; IP	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.01855509099009562
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.01855509099009562
IMMUNODEFICIENCY 47	0.000541419	0.01855509099009562
FABRY DISEASE	0.000541419	0.01855509099009562
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.01855509099009562
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.01855509099009562
HHHH SYNDROME	0.000541419	0.01855509099009562
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.01855509099009562
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.01855509099009562
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.01855509099009562
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.01855509099009562
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.01855509099009562
COWDEN SYNDROME 5; CWS5	0.000541419	0.01855509099009562
COWDEN SYNDROME 6; CWS6	0.000541419	0.01855509099009562
LISSENCEPHALY 5; LIS5	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.01855509099009562
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.01855509099009562
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.01855509099009562
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.01855509099009562
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.01855509099009562
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.01855509099009562
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.01855509099009562
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.01855509099009562
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.01855509099009562
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.01855509099009562
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.01855509099009562
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.01855509099009562
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.01855509099009562
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.01855509099009562
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.01855509099009562
SECKEL SYNDROME 7; SCKL7	0.000541419	0.01855509099009562
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.01855509099009562
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.01855509099009562
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.01855509099009562
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.01855509099009562
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.01855509099009562
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.01855509099009562
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.01855509099009562
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.01855509099009562
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.01855509099009562
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.01855509099009562
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.01855509099009562
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.01855509099009562
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.01855509099009562
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.01855509099009562
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.01855509099009562
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.01855509099009562
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.01855509099009562
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.01855509099009562
PERRAULT SYNDROME 3	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.01855509099009562
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.01855509099009562
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.01855509099009562
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.01855509099009562
TAY-SACHS DISEASE; TSD	0.000541419	0.01855509099009562
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.01855509099009562
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.01855509099009562
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.01855509099009562
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.01855509099009562
SNEDDON SYNDROME	0.000541419	0.01855509099009562
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.01855509099009562
STURGE-WEBER SYNDROME	0.000541419	0.01855509099009562
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.01855509099009562
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.01855509099009562
ALEXANDER DISEASE	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.01855509099009562
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.01855509099009562
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.01855509099009562
PARIETAL FORAMINA	0.000541419	0.01855509099009562
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.01855509099009562
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.01855509099009562
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.01855509099009562
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.01855509099009562
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.01855509099009562
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.01855509099009562
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.01855509099009562
CROME SYNDROME	0.000541419	0.01855509099009562
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.01855509099009562
DIAMINOPENTANURIA	0.000541419	0.01855509099009562
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.01855509099009562
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01855509099009562
DYSOSTEOSCLEROSIS	0.000541419	0.01855509099009562
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.01855509099009562
1P36 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.01855509099009562
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.01855509099009562
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.01855509099009562
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.01855509099009562
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.01855509099009562
PAPILLORENAL SYNDROME	0.000541419	0.01855509099009562
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.01855509099009562
CROUZON SYNDROME	0.000541419	0.01855509099009562
DARIER-WHITE DISEASE; DAR	0.000541419	0.01855509099009562
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.01855509099009562
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.01855509099009562
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.01855509099009562
FLYNN-AIRD SYNDROME	0.000541419	0.01855509099009562
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.01855509099009562
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.01855509099009562
HUNTINGTON DISEASE; HD	0.000541419	0.01855509099009562
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.01855509099009562
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.01855509099009562
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.01855509099009562
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.01855509099009562
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.01855509099009562
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.01855509099009562
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.01855509099009562
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.01855509099009562
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.01855509099009562
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.01855509099009562
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.01855509099009562
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.01855509099009562
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.01855509099009562
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.01855509099009562
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.01855509099009562
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.01855509099009562
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.01855509099009562
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.01855509099009562
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.01855509099009562
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.01855509099009562
NEURAMINIDASE DEFICIENCY	0.000541419	0.01855509099009562
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.01855509099009562
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01855509099009562
PHENYLKETONURIA	0.000541419	0.01855509099009562
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.01855509099009562
GITELMAN SYNDROME	0.000541419	0.01855509099009562
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.01855509099009562
RAMON SYNDROME	0.000541419	0.01855509099009562
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.01855509099009562
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.01855509099009562
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.01855509099009562
EPILEPSY-TELANGIECTASIA	0.000541419	0.01855509099009562
HYPERLYSINEMIA, TYPE I	0.000541419	0.01855509099009562
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.01855509099009562
FOUNTAIN SYNDROME	0.000541419	0.01855509099009562
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.01855509099009562
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.01855509099009562
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.01855509099009562
BERNARD-SOULIER SYNDROME	0.000541419	0.01855509099009562
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.01855509099009562
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.01855509099009562
HYPER-BETA-ALANINEMIA	0.000541419	0.01855509099009562
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.01855509099009562
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.01855509099009562
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.01855509099009562
HYPERPROLINEMIA, TYPE II	0.000541419	0.01855509099009562
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.01855509099009562
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.01855509099009562
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.01855509099009562
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.01855509099009562
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.01855509099009562
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.01855509099009562
KAPUR-TORIELLO SYNDROME	0.000541419	0.01855509099009562
KEUTEL SYNDROME; KTLS	0.000541419	0.01855509099009562
KIFAFA SEIZURE DISORDER	0.000541419	0.01855509099009562
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.01855509099009562
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.01855509099009562
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.01855509099009562
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.01855509099009562
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.01855509099009562
RAMON SYNDROME	0.000541419	0.01855509099009562
ISOLATED BILIARY ATRESIA	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.01855509099009562
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.01855509099009562
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.01855509099009562
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.01855509099009562
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.01855509099009562
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.01855509099009562
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.01855509099009562
NOCARDIOSIS	0.000541419	0.01855509099009562
PORENCEPHALY	0.000541419	0.01855509099009562
LUJO HEMORRHAGIC FEVER	0.000541419	0.01855509099009562
EBOLA HEMORRHAGIC FEVER	0.000541419	0.01855509099009562
RIFT VALLEY FEVER	0.000541419	0.01855509099009562
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.01855509099009562
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.01855509099009562
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.01855509099009562
RENPENNING SYNDROME	0.000541419	0.01855509099009562
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.01855509099009562
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.01855509099009562
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.01855509099009562
PROLACTINOMA	0.000541419	0.01855509099009562
CRONKHITE-CANADA SYNDROME	0.000541419	0.01855509099009562
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.01855509099009562
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.01855509099009562
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.000541419	0.01855509099009562
MICROSPORIDIOSIS	0.000541419	0.01855509099009562
MOYAMOYA DISEASE	0.000541419	0.01855509099009562
MOYNAHAN SYNDROME	0.000541419	0.01855509099009562
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.01855509099009562
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.01855509099009562
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.01855509099009562
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.01855509099009562
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.01855509099009562
CONGENITAL RUBELLA SYNDROME	0.000541419	0.01855509099009562
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.01855509099009562
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.01855509099009562
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.01855509099009562
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.01855509099009562
NASU-HAKOLA DISEASE	0.000541419	0.01855509099009562
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.01855509099009562
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.01855509099009562
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01855509099009562
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.01855509099009562
TYROSINEMIA TYPE 2	0.000541419	0.01855509099009562
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.01855509099009562
TAKAYASU ARTERITIS	0.000541419	0.01855509099009562
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.01855509099009562
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
HYPOPHOSPHATASIA	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.01855509099009562
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.01855509099009562
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.01855509099009562
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.01855509099009562
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.01855509099009562
WHIM SYNDROME	0.000541419	0.01855509099009562
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.01855509099009562
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.01855509099009562
LIPOID PROTEINOSIS	0.000541419	0.01855509099009562
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.01855509099009562
HYPERPROLINEMIA TYPE 1	0.000541419	0.01855509099009562
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.01855509099009562
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.01855509099009562
MYASTHENIA GRAVIS	0.000541419	0.01855509099009562
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.01855509099009562
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.01855509099009562
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.01855509099009562
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.01855509099009562
RECURRENT ACUTE PANCREATITIS	0.000541419	0.01855509099009562
NEVUS COMEDONICUS SYNDROME	0.000541419	0.01855509099009562
LHERMITTE-DUCLOS DISEASE	0.000541419	0.01855509099009562
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.01855509099009562
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.01855509099009562
MERCURY POISONING	0.000541419	0.01855509099009562
GALACTOSIALIDOSIS	0.000541419	0.01855509099009562
THYROCEREBRORENAL SYNDROME	0.000541419	0.01855509099009562
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.01855509099009562
VIRAL HEMORRHAGIC FEVER	0.000541419	0.01855509099009562
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.01855509099009562
WHIPPLE DISEASE	0.000541419	0.01855509099009562
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.01855509099009562
WOLFRAM SYNDROME	0.000541419	0.01855509099009562
WORSTER-DROUGHT SYNDROME	0.000541419	0.01855509099009562
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.01855509099009562
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.01855509099009562
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.01855509099009562
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.01855509099009562
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.01855509099009562
GLIOBLASTOMA	0.000541419	0.01855509099009562
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.01855509099009562
ADIPOSIS DOLOROSA	0.000541419	0.01855509099009562
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.01855509099009562
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.01855509099009562
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.01855509099009562
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.01855509099009562
CLASSIC HOMOCYSTINURIA	0.000541419	0.01855509099009562
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.01855509099009562
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.01855509099009562
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.01855509099009562
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.01855509099009562
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.01855509099009562
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.01855509099009562
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.01855509099009562
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.01855509099009562
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.01855509099009562
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.01855509099009562
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.01855509099009562
ROMANO-WARD SYNDROME	0.000541419	0.01855509099009562
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.01855509099009562
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.01855509099009562
BETA-MANNOSIDOSIS	0.000541419	0.01855509099009562
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.01855509099009562
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.01855509099009562
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.01855509099009562
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.01855509099009562
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.01855509099009562
BOWEN-CONRADI SYNDROME	0.000541419	0.01855509099009562
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.01855509099009562
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.01855509099009562
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.01855509099009562
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.01855509099009562
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.01855509099009562
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.01855509099009562
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.01855509099009562
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.01855509099009562
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.01855509099009562
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.01855509099009562
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.01855509099009562
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.01855509099009562
PSEUDO-TORCH SYNDROME 2	0.000541419	0.01855509099009562
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.01855509099009562
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.01855509099009562
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.01855509099009562
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.01855509099009562
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.01855509099009562
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.01855509099009562
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.01855509099009562
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.01855509099009562
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.01855509099009562
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.01855509099009562
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.01855509099009562
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.01855509099009562
AICA-RIBOSIDURIA	0.000541419	0.01855509099009562
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.01855509099009562
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.01855509099009562
CRIGLER-NAJJAR SYNDROME	0.000541419	0.01855509099009562
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.01855509099009562
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.01855509099009562
EPISODIC ATAXIA TYPE 6	0.000541419	0.01855509099009562
HARROD SYNDROME	0.000541419	0.01855509099009562
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.01855509099009562
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.01855509099009562
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.01855509099009562
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.01855509099009562
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.01855509099009562
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.000541419	0.01855509099009562
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.01855509099009562
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.01855509099009562
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.01855509099009562
SANJAD-SAKATI SYNDROME	0.000541419	0.01855509099009562
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.01855509099009562
4Q21 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
CITRULLINEMIA TYPE I	0.000541419	0.01855509099009562
JUVENILE HUNTINGTON DISEASE	0.000541419	0.01855509099009562
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.01855509099009562
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.01855509099009562
CORNELIA DE LANGE SYNDROME	0.000541419	0.01855509099009562
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.01855509099009562
DISTAL MONOSOMY 7Q36	0.000541419	0.01855509099009562
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.01855509099009562
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.01855509099009562
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.01855509099009562
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.01855509099009562
CRISPONI SYNDROME	0.000541419	0.01855509099009562
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.01855509099009562
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.01855509099009562
KNOBLOCH SYNDROME	0.000541419	0.01855509099009562
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.01855509099009562
ROSAÏ-DORFMAN DISEASE	0.000541419	0.01855509099009562
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01855509099009562
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.01855509099009562
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.01855509099009562
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.01855509099009562
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.01855509099009562
CENTRAL DIABETES INSIPIDUS	0.000541419	0.01855509099009562
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.01855509099009562
FRONTAL ENCEPHALOCELE	0.000541419	0.01855509099009562
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.01855509099009562
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.01855509099009562
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.01855509099009562
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.01855509099009562
